rfhg_74441.1

Basic information about the TSS

---

TSS ID: rfhg_74441.1 Species: human Chr: chr5		Start: 151259871 End: 151259889 Strand: +
Source datasets	FANTOM5
Protocol	CAGE
TSS cluster detected*	1

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	-
Category:	-

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: ENST00000523004.1:-72 X61094:-72 GeneID: 2760 HGNC/MGI_ID: HGNC:4367 UniProt_ID: H0YBY3 Q14427 Nearer transcript ids and distances:

Gene_name: ganglioside GM2 activator Gene_symbol: GM2A Gene_synonyms: GM2-AP GM2AP SAP-3 Gene_source: HGNC:4367

TATA-Box annotation

---

Distance to TSS:	6695
Nearest PromoterID:	NM_000405
Entrez ID:	2760
Nearest Unigene:	Hs.483873
Nearest Refseq:	NM_000405
Nearest Ensembl:	ENSG00000196743
Gene Name:	ganglioside GM2 activator
Gene Alias:	GM2-AP|SAP-3
Gene Type:	protein-coding
CpG%:	0.000000
GC%:	0.631579
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@GM2A p2@GM2A p3@GM2A p4@GM2A p5@GM2A p6@GM2A p7@GM2A p8@GM2A
Sample		p1@GM2A	p2@GM2A	p3@GM2A	p4@GM2A	p5@GM2A	p6@GM2A	p7@GM2A	p8@GM2A
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	17.92	3.12	0.58	0.58	0.19	0.19	0.00	0.00
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	17.40	3.84	2.23	1.82	0.20	0.40	0.00	0.00
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	16.98	3.47	2.12	0.96	0.58	0.58	0.00	0.00
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	16.42	5.20	1.25	0.83	0.00	1.04	0.00	0.00
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	16.20	5.85	1.35	0.90	0.22	0.22	0.00	0.00
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	20.54	4.65	0.19	1.74	0.78	0.19	0.00	0.00
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	13.94	5.45	2.40	1.53	0.00	0.00	0.00	0.00
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	15.26	2.66	1.70	1.45	0.00	0.73	0.00	0.00
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	12.82	4.06	1.50	0.21	0.00	0.43	0.00	0.00
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	5.22	0.00	1.16	1.74	0.00	0.00	0.00	0.00
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	5.26	1.21	1.62	2.02	0.00	0.00	0.00	0.00
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	4.88	2.03	0.41	1.63	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	9.83	8.06	3.39	1.45	0.81	0.81	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	13.53	7.82	2.56	1.95	0.60	0.15	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	8.78	6.59	3.07	2.63	0.22	0.22	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	12.57	9.05	3.52	2.01	0.00	0.25	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	12.23	8.08	3.28	1.97	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	13.50	8.01	1.69	3.37	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	13.33	9.60	4.27	3.20	0.00	0.53	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	8.42	6.92	1.96	0.90	0.60	0.15	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	11.09	6.68	2.14	1.20	0.80	0.13	0.00	0.13
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	9.32	8.63	1.90	1.38	0.52	0.35	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	11.50	8.40	2.71	1.16	0.52	0.13	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	11.16	5.10	2.43	0.24	0.97	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	8.26	6.19	2.06	1.29	0.52	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	9.81	6.33	2.22	0.63	0.32	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	17.58	6.59	3.30	1.65	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	11.79	8.49	3.54	2.36	1.18	0.71	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	9.85	10.18	2.58	1.45	0.65	0.16	0.00	0.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	9.95	7.60	1.63	2.17	0.54	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	11.10	6.07	1.47	2.09	0.21	0.42	0.00	0.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	8.40	6.25	3.32	1.76	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	14.35	6.33	2.74	1.27	0.00	0.42	0.21	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	13.85	7.59	2.31	1.65	0.33	0.16	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	10.66	3.74	1.50	1.12	0.37	0.75	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	8.81	7.09	1.92	1.15	0.57	0.19	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	7.56	3.27	2.45	0.61	0.20	0.61	0.00	0.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	9.87	5.24	2.42	1.01	0.81	0.60	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	8.64	4.05	1.62	1.62	0.81	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	7.68	3.84	2.40	0.72	0.24	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	9.41	4.00	2.59	1.18	0.47	0.47	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	11.86	6.44	2.20	1.90	0.29	0.15	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	8.44	5.48	2.74	1.27	0.42	0.42	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	9.79	4.72	2.10	1.92	0.17	0.35	0.00	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	10.64	5.42	2.61	1.20	0.60	0.20	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	9.54	5.82	1.86	0.93	0.70	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	10.08	4.56	3.36	0.72	0.00	0.48	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	6.56	4.17	2.09	0.30	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	9.34	4.07	2.87	0.96	0.96	0.48	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	9.91	3.44	1.82	1.21	0.81	0.61	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	9.84	4.71	0.82	1.64	0.82	0.20	0.00	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	5.34	6.89	2.00	0.44	0.67	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	13.99	0.00	13.99	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	9.23	6.39	2.84	1.42	0.35	0.35	0.00	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	10.60	3.98	0.66	0.66	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	15.94	6.71	4.19	3.36	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	10.56	9.64	3.67	0.46	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	8.75	2.59	2.92	1.30	0.00	0.65	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	7.71	1.93	1.28	0.64	0.64	0.32	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	11.00	5.03	2.51	1.57	0.31	0.31	0.00	0.31
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	5.64	7.05	1.41	0.00	0.71	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	8.97	2.80	2.80	1.12	1.12	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	11.15	1.59	1.59	1.59	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	6.80	3.40	1.70	1.70	0.34	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	4.55	3.25	1.30	0.97	0.00	0.32	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	5.32	2.13	2.13	0.35	0.35	0.35	0.00	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	7.90	0.00	7.90	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	9.26	4.88	1.95	2.44	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	7.93	4.96	4.46	0.99	0.00	0.00	0.00	0.99
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	12.67	5.16	4.69	1.41	0.47	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	13.25	4.64	4.97	1.99	0.99	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	10.21	4.95	2.78	1.55	0.31	0.62	0.00	0.31
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	11.92	5.81	1.83	1.53	0.31	0.31	0.00	0.00
Adipocyte - breast, donor1	11376-118A8	39.60	15.84	19.64	5.07	2.22	2.85	0.00	0.16
Adipocyte - breast, donor2	11327-117E4	42.99	8.98	10.43	6.42	1.93	0.80	0.00	0.32
Adipocyte - omental, donor1	11473-119C6	66.16	15.27	20.74	8.02	2.54	3.31	0.00	0.25
Adipocyte - omental, donor2	11474-119C7	21.68	9.72	11.96	2.99	2.99	0.75	0.00	0.75
Adipocyte - omental, donor3	11475-119C8	34.50	6.36	12.06	2.01	3.01	2.34	0.00	1.34
Adipocyte - perirenal, donor1	11476-119C9	37.64	10.85	12.76	5.10	2.55	3.19	0.00	0.00
Adipocyte - subcutaneous, donor1	11259-116F8	7.70	3.30	4.40	0.00	0.00	0.00	0.00	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	40.65	9.48	16.71	5.87	1.81	1.35	0.00	0.00
Adipocyte - subcutaneous, donor3	11408-118E4	13.55	6.78	11.47	5.04	3.30	1.74	0.00	0.00
Adipocyte differentiation, day04, donor1	13019-139D4	68.06	15.84	18.97	8.02	5.28	3.32	0.20	0.00
Adipocyte differentiation, day04, donor2	13022-139D7	70.01	9.78	12.87	6.43	1.03	1.80	0.00	0.00
Adipocyte differentiation, day04, donor3	13025-139E1	100.36	10.31	13.94	6.13	3.35	1.39	0.28	0.28
Adipocyte differentiation, day04, donor4	13028-139E4	52.90	5.88	25.28	7.64	2.94	1.76	0.00	0.00
Adipocyte differentiation, day08, donor1	13020-139D5	128.05	11.18	15.85	6.84	2.57	2.98	0.00	0.16
Adipocyte differentiation, day08, donor2	13023-139D8	279.83	13.23	20.33	13.88	2.58	4.20	0.00	0.00
Adipocyte differentiation, day08, donor3	13026-139E2	125.83	6.93	24.53	11.20	3.73	3.20	0.00	0.53
Adipocyte differentiation, day08, donor4	13029-139E5	80.13	7.23	21.14	3.90	0.56	3.90	0.00	0.00
Adipocyte differentiation, day12, donor1	13021-139D6	91.08	6.24	9.15	4.16	2.08	1.66	0.00	0.00
Adipocyte differentiation, day12, donor2	13024-139D9	403.87	7.53	20.34	9.80	2.26	3.52	0.00	1.00
Adipocyte differentiation, day12, donor3	13027-139E3	234.96	8.84	12.44	10.14	1.31	1.64	0.00	0.00
Adipocyte differentiation, day12, donor4	13030-139E6	107.48	4.26	7.00	4.87	0.91	1.83	0.00	0.00
Alveolar Epithelial Cells, donor1	11510-119G7	37.57	15.25	5.75	2.87	0.66	1.10	0.00	0.00
Alveolar Epithelial Cells, donor2	11590-120G6	37.65	5.74	5.38	2.15	1.43	0.00	0.00	0.00
Alveolar Epithelial Cells, donor3	11671-122G6	23.96	9.58	5.99	4.79	3.59	1.20	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	85.99	38.50	14.39	6.66	1.62	1.62	0.18	0.00
Amniotic Epithelial Cells, donor2	11613-122A2	48.53	40.16	5.02	10.04	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	77.04	23.83	8.01	8.63	1.03	0.62	0.00	0.00
Anulus Pulposus Cell, donor1	11248-116E6	32.61	25.17	14.65	4.12	1.72	1.60	0.00	0.11
Anulus Pulposus Cell, donor2	11463-119B5	19.35	9.06	5.88	1.96	0.24	0.49	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	120.41	8.54	11.68	6.74	0.45	1.80	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	39.94	10.42	14.33	5.21	0.43	2.60	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	19.26	4.28	6.42	8.56	0.00	2.14	2.14	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	165.30	11.96	8.37	6.28	1.49	1.20	0.00	0.60
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	32.88	12.65	7.59	6.32	1.26	2.53	0.00	1.26
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	16.50	7.92	9.24	3.96	0.66	0.66	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	90.64	10.72	8.12	5.52	0.97	1.30	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	33.50	11.65	7.28	4.85	0.97	1.94	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	22.57	7.13	4.16	4.75	0.59	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	40.30	10.17	9.04	4.90	0.00	1.13	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	35.56	11.61	13.06	5.08	0.73	0.73	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	22.57	7.52	8.78	1.25	0.00	1.25	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	26.69	13.51	11.20	4.78	1.48	2.14	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	39.58	15.01	6.82	1.36	1.36	0.00	0.00	1.36
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	20.81	8.44	6.33	2.56	0.75	0.45	0.15	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	64.83	10.18	13.93	5.36	1.07	1.07	0.00	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	20.78	7.56	7.37	4.16	1.13	1.51	0.00	0.19
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	25.12	10.42	9.62	4.81	0.80	0.53	0.00	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	113.15	6.83	11.71	6.83	0.00	1.95	0.00	0.98
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	23.88	7.63	9.29	3.48	1.82	0.17	0.17	0.17
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	25.22	13.21	10.81	2.40	0.00	1.20	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	42.48	17.70	7.08	10.62	7.08	3.54	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	25.39	8.40	9.78	4.97	1.03	0.51	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	16.78	4.19	0.00	8.39	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	28.64	11.16	10.19	2.91	0.49	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	27.32	7.97	6.07	3.79	0.76	1.52	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	26.65	4.85	10.90	4.85	0.00	1.21	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	27.93	9.12	7.98	3.42	0.00	1.14	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	24.58	9.19	12.40	3.63	1.07	0.64	0.00	0.21
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	13.94	9.81	6.71	3.87	0.77	1.03	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	34.72	11.26	10.79	4.69	0.47	1.41	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	25.08	11.25	12.22	5.79	0.32	1.61	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	20.69	8.56	4.99	3.57	0.71	1.43	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	29.83	13.45	11.11	5.85	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	20.77	10.54	7.23	3.01	0.90	1.20	0.30	0.90
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	28.51	9.50	11.88	4.75	0.00	1.19	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	32.55	8.65	10.68	4.07	0.51	0.51	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	22.41	6.37	5.35	4.84	0.51	0.51	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	13.34	8.90	5.08	3.81	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	23.30	11.22	14.24	7.77	0.00	2.16	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	24.34	9.53	7.41	2.75	1.06	1.06	0.00	0.21
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	17.69	7.83	8.12	4.64	0.58	1.45	0.00	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	16.06	12.28	11.34	5.67	0.00	1.89	0.00	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	26.95	9.49	9.15	4.24	1.36	0.85	0.00	0.34
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	13.90	11.58	4.63	0.00	0.00	2.32	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	31.69	16.90	12.68	4.23	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	29.37	9.01	9.86	4.29	0.86	0.86	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	18.65	10.23	11.43	4.21	0.00	0.60	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	25.51	8.02	3.64	3.64	2.19	3.64	0.00	0.73
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	26.90	9.43	9.66	4.37	1.15	1.84	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	17.85	17.85	5.10	5.10	5.10	0.00	0.00	2.55
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	20.59	6.61	7.63	3.05	0.00	0.76	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	25.60	9.70	9.91	5.16	0.83	1.03	0.00	0.21
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	24.48	8.26	5.20	3.98	0.61	0.61	0.00	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	36.33	11.95	10.04	4.78	0.48	0.96	0.00	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	22.40	10.87	9.98	5.10	1.55	1.11	0.00	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	13.73	9.15	9.15	1.53	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	21.60	7.75	6.09	4.43	0.00	0.00	0.00	0.55
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	20.92	6.62	9.00	4.24	1.06	1.06	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	17.45	8.72	6.91	5.82	1.45	0.36	0.00	0.00
Astrocyte - cerebellum, donor1	11500-119F6	48.64	22.11	12.28	2.46	2.09	1.60	0.00	0.00
Astrocyte - cerebellum, donor2	11580-120F5	23.96	9.41	5.13	2.40	1.20	0.17	0.00	0.17
Astrocyte - cerebellum, donor3	11661-122F5	19.51	7.76	8.81	3.36	3.99	1.26	0.00	0.00
Astrocyte - cerebral cortex, donor1	11235-116D2	16.38	7.32	17.08	2.44	4.88	3.14	0.00	0.00
Astrocyte - cerebral cortex, donor2	11316-117D2	16.02	8.57	7.93	2.59	1.62	1.13	0.00	0.00
Astrocyte - cerebral cortex, donor3	11392-118C6	16.41	4.33	7.16	2.83	2.98	0.75	0.00	0.15
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	319.51	30.16	18.58	20.87	5.96	4.01	19.50	0.11
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	281.38	23.30	18.29	19.54	3.51	2.76	19.92	0.63
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	261.85	20.71	13.77	18.21	3.76	2.50	16.84	0.00
Basophils, donor1	12241-129G9	65.38	6.80	13.34	8.11	1.57	0.52	1.31	0.00
Basophils, donor2	12242-129H1	95.25	17.32	10.82	8.30	0.00	0.36	0.36	0.00
Basophils, donor3	12243-129H2	90.11	14.41	16.32	7.50	1.03	0.59	1.32	0.00
Bronchial Epithelial Cell, donor1	11511-119G8	633.44	47.86	15.95	22.21	9.06	2.59	0.00	0.86
Bronchial Epithelial Cell, donor2	11591-120G7	458.10	30.17	8.23	19.66	2.29	0.46	0.00	2.29
Bronchial Epithelial Cell, donor3	11672-122G7	588.23	28.69	57.39	21.52	7.17	7.17	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	163.82	10.04	8.16	8.79	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor5	11457-119A8	218.35	19.55	7.28	12.27	2.08	0.62	0.00	0.83
Bronchial Epithelial Cell, donor6	11461-119B3	207.03	16.58	7.83	9.67	2.07	0.23	0.00	0.23
Bronchial Epithelial Cell, donor7	11769-123I5	373.75	26.99	19.43	24.83	5.04	2.34	0.00	1.08
Burkitt's lymphoma cell line:DAUDI	10422-106C8	272.99	11.13	7.63	4.43	3.40	2.06	2.47	0.10
Burkitt's lymphoma cell line:RAJI	10476-106I8	133.69	14.44	3.03	1.40	1.63	0.23	16.77	0.00
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	55.32	14.07	15.67	5.12	2.88	1.60	0.96	0.00
CD133+ stem cells - cord blood derived, pool1	12223-129E9	10.34	31.03	10.34	0.00	0.00	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	134.69	15.78	19.16	7.33	0.00	1.69	0.00	0.00
CD14+ Monocytes, donor2	11305-117B9	146.44	14.29	16.52	15.96	1.11	1.86	0.37	0.37
CD14+ Monocytes, donor3	11381-118B4	135.89	13.61	14.93	8.12	0.88	1.54	0.22	0.22
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	1279.93	77.55	75.86	49.82	8.21	7.64	0.00	0.57
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	1940.10	82.64	62.93	58.00	8.34	7.58	0.00	3.03
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	1286.03	73.64	87.77	56.87	15.12	11.51	0.33	1.31
CD14+ monocytes - mock treated, donor1	11863-125A9	173.17	21.39	11.85	8.53	0.58	0.29	0.58	1.01
CD14+ monocytes - mock treated, donor2	11873-125C1	156.60	20.52	8.45	6.34	0.91	1.21	0.30	0.30
CD14+ monocytes - mock treated, donor3	11883-125D2	105.89	13.74	6.40	7.11	0.47	0.71	1.66	0.24
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	165.05	14.90	10.38	8.87	0.84	0.67	2.18	0.33
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	178.86	14.90	12.70	9.94	1.10	1.93	0.55	0.28
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	175.78	17.60	10.17	8.18	0.25	0.50	2.98	0.25
CD14+ monocytes - treated with BCG, donor1	11860-125A6	198.74	22.13	10.77	11.55	1.17	0.59	0.39	0.59
CD14+ monocytes - treated with BCG, donor2	11870-125B7	220.07	20.12	15.13	10.68	0.53	1.60	0.18	0.36
CD14+ monocytes - treated with BCG, donor3	11880-125C8	196.30	21.33	15.23	11.10	1.31	1.52	0.65	0.44
CD14+ monocytes - treated with Candida, donor1	11868-125B5	254.96	17.56	13.58	10.54	2.11	1.40	1.17	0.00
CD14+ monocytes - treated with Candida, donor2	11878-125C6	360.64	18.48	21.12	9.50	1.58	1.06	2.11	0.00
CD14+ monocytes - treated with Candida, donor3	11888-125D7	309.51	18.86	14.42	8.87	3.33	5.55	2.22	1.11
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	174.93	20.82	10.41	12.20	0.74	0.89	1.64	0.30
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	156.05	17.16	10.38	8.38	0.60	0.40	0.60	0.40
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	100.98	14.37	7.50	6.87	0.83	1.25	6.66	0.21
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	202.25	21.28	13.04	12.13	0.23	0.46	3.89	0.69
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	214.89	18.10	11.76	9.05	0.68	1.13	1.58	0.23
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	113.92	14.84	9.60	6.11	0.87	0.44	2.62	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	184.26	20.44	12.37	14.79	1.34	0.27	0.00	0.54
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	242.50	28.26	16.05	14.13	0.87	1.92	0.00	0.70
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	154.86	14.73	11.36	10.52	0.42	2.52	0.00	0.42
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	261.05	14.15	13.96	12.86	2.39	0.37	2.20	0.92
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	249.76	12.68	11.27	9.51	0.35	2.82	2.11	0.35
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	174.61	11.41	6.58	6.14	0.00	1.75	9.21	0.88
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	206.28	19.70	11.86	10.29	0.70	1.22	0.17	0.35
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	233.78	18.96	14.87	8.55	1.49	0.74	0.74	0.74
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	207.36	24.79	17.46	15.30	1.72	1.94	0.43	1.08
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	258.39	18.43	12.28	16.79	0.41	0.41	2.46	0.41
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	338.43	22.95	17.85	12.05	1.62	2.32	1.85	0.70
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	164.71	15.54	10.90	7.19	0.70	1.86	6.03	0.46
CD14+CD16+ Monocytes, donor1	11789-124B7	46.86	8.50	12.21	8.94	0.65	1.74	0.00	0.00
CD14+CD16+ Monocytes, donor2	11801-124D1	75.54	17.79	16.17	9.70	1.62	1.15	0.00	0.46
CD14+CD16+ Monocytes, donor3	11912-125G4	42.67	8.66	12.13	5.63	0.87	0.87	0.00	0.22
CD14+CD16- Monocytes, donor1	11788-124B6	259.43	38.93	40.33	20.24	2.18	2.49	0.16	0.47
CD14+CD16- Monocytes, donor2	11799-124C8	261.27	32.48	30.21	18.86	1.57	1.92	0.00	0.52
CD14+CD16- Monocytes, donor3	11910-125G2	184.40	26.31	38.80	25.42	1.34	2.45	0.00	0.67
CD14-CD16+ Monocytes, donor1	11790-124B8	13.78	2.55	6.12	2.81	0.77	0.26	0.00	0.00
CD14-CD16+ Monocytes, donor2	11800-124C9	23.05	6.15	6.37	3.51	0.66	0.22	0.22	0.00
CD14-CD16+ Monocytes, donor3	11911-125G3	13.05	3.37	5.26	1.68	0.21	0.42	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	152.42	0.00	6.10	4.06	0.00	2.03	4.06	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	155.26	9.49	5.42	12.88	6.10	0.68	6.78	0.00
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	140.84	11.39	7.25	7.25	2.07	1.04	7.25	0.00
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	157.25	8.53	14.39	7.46	2.13	4.26	4.80	0.00
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	158.68	10.19	10.72	5.90	4.29	2.14	9.65	0.00
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	120.03	7.72	8.42	3.51	3.51	1.40	10.53	0.00
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	132.56	5.49	3.92	3.14	4.71	2.35	8.63	0.00
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	164.79	9.23	13.18	9.23	1.32	0.00	9.23	0.00
CD19+ B Cells, donor1	11544-120B5	84.66	6.58	4.93	6.58	0.82	2.47	9.04	0.00
CD19+ B Cells, donor2	11624-122B4	91.40	7.98	8.71	5.80	1.45	0.00	3.63	0.73
CD19+ B Cells, donor3	11705-123B4	120.65	10.10	7.57	4.54	3.03	2.52	1.01	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	19.39	6.46	3.64	0.00	0.81	0.40	0.00	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	14.38	2.80	1.20	1.20	0.40	0.40	0.00	0.40
CD34+ Progenitors, donor1	11545-120B6	16.06	5.02	4.02	2.01	0.00	1.00	1.00	0.00
CD34+ Progenitors, donor2	11625-122B5	47.19	8.99	3.93	1.12	0.00	0.00	1.12	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	48.10	14.65	9.77	4.88	1.13	0.75	1.50	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	59.30	15.11	11.95	5.86	2.93	2.03	1.80	0.00
CD4+ T Cells, donor1	11225-116C1	11.43	2.86	3.93	0.36	1.43	1.43	7.50	0.00
CD4+ T Cells, donor2	11306-117C1	6.12	4.90	2.45	0.61	0.61	0.00	4.90	0.00
CD4+ T Cells, donor3	11382-118B5	8.84	2.44	1.83	0.91	0.91	0.61	2.13	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	53.85	27.31	8.93	2.81	3.32	1.53	1.28	0.51
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	47.17	24.93	9.66	2.92	2.70	2.70	1.12	0.22
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	29.32	17.82	7.76	2.30	0.86	1.72	1.44	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	4.27	6.16	2.84	1.42	2.37	1.90	1.42	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	9.83	3.51	1.40	0.00	1.40	0.70	1.40	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	3.30	3.30	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	64.02	25.87	11.27	6.07	2.31	3.18	5.20	0.14
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	49.65	24.57	9.66	3.73	2.03	2.20	0.51	0.17
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	36.11	20.15	9.03	2.42	1.93	1.13	0.81	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	13.45	9.41	3.59	1.34	0.90	0.45	1.34	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	13.63	11.18	3.49	1.05	2.10	1.40	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	9.68	9.24	4.40	0.88	2.64	0.00	1.76	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	25.72	14.76	7.17	4.22	3.37	2.53	2.95	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	16.62	12.47	6.23	1.45	1.87	0.62	2.29	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	11.03	5.35	5.01	2.00	1.00	0.67	1.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	5.71	2.99	4.08	0.82	2.45	1.36	3.81	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	8.58	1.61	6.43	0.00	4.82	0.00	3.75	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	3.59	7.17	5.38	0.00	1.79	0.00	3.59	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	32.26	15.02	5.75	1.30	1.30	1.67	1.11	0.19
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	20.80	11.91	8.88	2.38	1.30	0.65	0.43	0.43
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	15.34	9.04	5.67	1.47	1.47	0.42	0.42	0.21
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	6.07	5.56	3.03	1.52	1.01	0.00	3.03	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	8.23	5.63	2.17	1.30	2.60	0.43	1.73	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	6.10	6.10	3.49	1.31	0.44	0.44	3.92	0.00
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	10.89	11.38	5.44	2.97	1.48	0.99	1.98	0.00
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	4.62	7.39	0.92	0.00	0.00	0.00	0.92	0.00
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	9.77	4.19	0.00	0.00	1.40	0.00	2.79	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	18.83	6.09	5.54	2.49	1.38	0.28	1.94	0.00
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	21.10	7.61	4.66	1.23	2.45	0.74	3.19	0.00
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	15.40	4.62	9.24	0.00	1.54	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	19.70	9.67	3.94	2.51	1.07	1.43	2.15	0.00
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	8.31	4.15	5.54	1.38	0.00	2.77	1.38	0.00
CD8+ T Cells, donor1	11226-116C2	5.89	4.58	1.64	0.98	0.33	0.65	1.96	0.00
CD8+ T Cells, donor2	11307-117C2	4.88	2.63	2.63	0.38	1.13	0.75	0.38	0.00
CD8+ T Cells, donor3	11383-118B6	4.29	1.51	2.78	0.00	0.76	0.50	2.27	0.00
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	28.22	5.05	2.98	2.06	0.46	0.46	0.00	0.46
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	32.11	6.23	4.07	2.88	0.00	0.96	0.00	0.24
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	31.46	3.83	3.56	3.28	0.27	0.55	0.00	0.27
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	44.73	5.70	4.50	6.30	1.50	0.60	0.30	0.00
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	31.20	4.08	6.00	2.40	0.96	0.48	0.00	0.00
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	33.88	5.91	3.64	2.73	0.45	0.23	0.00	0.00
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	30.85	6.08	2.17	1.96	0.43	0.43	0.00	0.00
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	33.43	6.84	2.90	1.32	0.00	0.00	0.00	0.00
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	31.89	4.22	1.88	2.58	0.23	0.00	0.00	0.00
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	35.62	7.85	1.81	3.02	0.30	0.60	0.00	0.30
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	33.12	5.52	2.32	1.74	0.87	0.00	0.00	0.00
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	30.37	6.93	1.87	2.66	0.80	0.27	0.00	0.00
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	34.14	3.06	1.31	0.44	0.00	0.00	0.00	0.00
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	42.35	4.55	0.91	0.91	0.91	0.46	0.00	0.00
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	32.07	0.00	0.75	0.75	0.75	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	34.57	6.84	3.60	3.24	1.80	0.36	0.36	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	29.06	6.33	4.03	3.74	1.15	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	26.16	4.01	3.54	4.95	0.47	0.47	0.00	0.24
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	22.50	5.39	4.44	0.95	0.95	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	22.14	3.08	0.92	0.31	0.31	0.62	0.00	0.62
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	29.81	6.41	2.56	1.92	0.32	0.00	0.00	0.32
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	25.24	6.88	3.06	1.53	0.76	0.38	0.00	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	26.41	5.91	3.15	1.18	0.79	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	19.67	4.54	4.54	3.03	0.00	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	56.21	2.41	1.61	1.61	0.00	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	62.95	0.00	0.00	2.10	0.70	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	49.09	0.00	1.00	1.00	0.00	0.00	0.00	0.00
Cardiac Myocyte, donor1	11525-119I4	45.69	14.62	14.62	9.14	0.00	1.83	0.00	0.00
Cardiac Myocyte, donor2	11605-120I3	31.62	18.78	6.42	3.46	0.49	0.49	0.00	0.00
Cardiac Myocyte, donor3	11686-122I3	21.05	13.36	9.47	3.26	3.16	1.89	0.00	0.00
Chondrocyte - de diff, donor1	11261-116G1	17.68	6.93	14.21	2.77	1.04	1.39	0.00	0.35
Chondrocyte - de diff, donor2	11338-117F6	13.15	7.46	8.17	1.42	0.36	1.07	0.00	0.36
Chondrocyte - de diff, donor3	11410-118E6	12.86	6.94	8.31	3.41	1.93	0.46	0.00	0.00
Chondrocyte - re diff, donor2	11339-117F7	20.59	14.32	14.32	4.48	0.90	0.00	0.00	0.00
Chondrocyte - re diff, donor3	11411-118E7	10.11	4.04	9.30	4.04	4.45	1.21	0.00	0.00
Ciliary Epithelial Cells, donor1	11242-116D9	29.49	17.21	11.82	2.87	2.07	1.61	0.00	0.23
Ciliary Epithelial Cells, donor2	11323-117D9	13.25	8.12	4.70	1.28	0.64	0.64	0.00	0.00
Ciliary Epithelial Cells, donor3	11399-118D4	21.68	9.82	4.25	2.39	1.33	0.97	0.00	0.35
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	75.74	8.80	22.10	8.44	2.75	2.84	0.18	0.00
Corneal Epithelial Cells, donor1	11526-119I5	421.80	46.11	20.86	16.47	7.69	3.07	0.00	1.10
Corneal Epithelial Cells, donor2	11606-120I4	299.19	29.58	10.24	29.58	4.55	2.28	0.00	1.14
Corneal Epithelial Cells, donor3	11687-122I4	206.04	24.03	14.06	14.57	4.09	1.02	0.00	0.00
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	4885.84	53.82	38.47	56.79	6.11	4.62	0.00	2.97
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	4963.91	52.36	37.53	59.61	8.83	5.68	0.00	1.58
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	2384.43	44.86	27.61	58.66	3.45	3.45	3.45	6.90
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	3444.22	32.40	24.84	46.11	5.40	2.92	0.00	8.10
Dendritic Cells - plasmacytoid, donor1	11228-116C4	73.11	25.28	19.47	5.12	4.10	1.37	26.31	0.00
Dendritic Cells - plasmacytoid, donor2	11309-117C4	99.89	21.54	11.75	9.14	2.61	1.31	11.10	0.00
Dendritic Cells - plasmacytoid, donor3	11385-118B8	111.31	16.94	14.52	3.39	4.36	4.84	23.23	0.00
Endothelial Cells - Aortic, donor0	11207-116A1	14.84	5.34	4.67	1.67	0.50	1.17	0.00	0.00
Endothelial Cells - Aortic, donor1	11263-116G3	19.95	3.52	4.11	1.76	0.59	0.59	0.59	0.00
Endothelial Cells - Aortic, donor2	11340-117F8	16.97	8.48	6.50	2.83	0.85	0.85	0.00	0.00
Endothelial Cells - Aortic, donor3	11412-118E8	11.01	7.47	5.11	3.93	0.79	0.39	0.00	0.00
Endothelial Cells - Artery, donor1	11264-116G4	20.94	10.18	7.27	5.53	0.58	2.91	0.00	0.00
Endothelial Cells - Artery, donor2	11341-117F9	21.18	9.41	4.94	2.12	0.24	0.47	0.00	0.24
Endothelial Cells - Artery, donor3	11413-118E9	15.08	9.47	6.14	2.63	1.23	1.05	0.18	0.00
Endothelial Cells - Lymphatic, donor1	11236-116D3	51.42	21.72	11.08	5.54	0.89	0.89	0.44	0.00
Endothelial Cells - Lymphatic, donor2	11317-117D3	62.37	27.69	17.65	3.65	2.13	2.13	0.30	0.00
Endothelial Cells - Lymphatic, donor3	11393-118C7	38.34	14.10	12.69	3.95	1.97	1.41	0.00	0.00
Endothelial Cells - Microvascular, donor1	11265-116G5	32.09	15.15	9.21	1.49	1.19	0.30	0.30	0.00
Endothelial Cells - Microvascular, donor2	11342-117G1	18.22	10.93	8.85	3.64	0.00	2.08	0.52	0.00
Endothelial Cells - Microvascular, donor3	11414-118F1	15.03	10.35	4.25	1.56	1.42	0.43	0.00	0.00
Endothelial Cells - Thoracic, donor1	11266-116G6	27.61	15.20	12.40	2.80	2.40	0.40	0.00	0.00
Endothelial Cells - Thoracic, donor2	11343-117G2	13.63	6.81	5.24	4.19	0.52	1.05	0.00	0.52
Endothelial Cells - Umbilical vein, donor1	11243-116E1	39.51	23.48	10.31	6.46	1.24	0.99	0.00	0.12
Endothelial Cells - Umbilical vein, donor2	11324-117E1	18.68	9.78	3.69	2.61	1.74	0.22	0.00	0.22
Endothelial Cells - Umbilical vein, donor3	11400-118D5	17.95	10.14	5.37	3.18	1.34	0.73	0.12	0.00
Endothelial Cells - Vein, donor1	11267-116G7	5.69	2.28	2.28	0.00	1.14	0.00	0.00	0.00
Endothelial Cells - Vein, donor2	11344-117G3	11.87	5.59	7.68	0.70	1.40	0.70	0.00	0.00
Endothelial Cells - Vein, donor3	11416-118F3	11.78	5.34	5.34	1.41	0.47	0.63	0.47	0.00
Eosinophils, donor1	12244-129H3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	31.35	1.65	4.95	1.65	0.00	0.00	84.16	0.00
Eosinophils, donor3	12246-129H5	21.40	3.57	7.13	3.57	0.00	0.00	42.80	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	553.89	48.38	15.88	15.39	4.64	2.20	0.00	0.24
Esophageal Epithelial Cells, donor2	11587-120G3	262.10	10.40	16.64	18.72	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	520.60	48.81	16.27	16.27	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	12.73	5.75	4.52	2.46	1.23	1.23	0.00	0.00
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	39.63	8.43	7.12	6.35	1.53	1.09	0.00	0.88
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	4.33	6.39	0.98	0.54	0.00	0.00	0.00	0.00
Fibroblast - Aortic Adventitial, donor1	11245-116E3	24.50	9.46	11.76	5.70	1.33	0.97	0.00	0.12
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	51.72	9.83	12.96	5.87	2.32	2.18	0.00	0.00
Fibroblast - Aortic Adventitial, donor2	11326-117E3	35.33	14.66	9.60	7.91	1.58	1.37	0.00	0.11
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	79.84	23.45	29.25	10.80	3.69	5.80	0.00	0.79
Fibroblast - Aortic Adventitial, donor3	11401-118D6	59.13	13.62	7.31	6.31	1.33	1.00	0.00	0.33
Fibroblast - Cardiac, donor1	11268-116G8	18.15	2.72	6.35	2.72	2.27	0.45	0.00	0.00
Fibroblast - Cardiac, donor2	11345-117G4	8.34	4.55	3.79	0.76	0.76	0.76	0.00	0.00
Fibroblast - Cardiac, donor3	11417-118F4	13.56	3.31	5.52	3.31	1.10	0.95	0.00	0.00
Fibroblast - Cardiac, donor4	11452-119A3	42.74	18.19	14.85	6.97	1.52	1.21	0.00	0.61
Fibroblast - Cardiac, donor5	11456-119A7	17.26	7.23	4.19	1.78	0.63	0.51	0.00	0.00
Fibroblast - Cardiac, donor6	11460-119B2	20.62	8.19	4.09	2.43	0.76	0.45	0.00	0.15
Fibroblast - Choroid Plexus, donor1	11492-119E7	30.42	13.40	15.41	3.75	1.61	3.89	0.00	0.27
Fibroblast - Choroid Plexus, donor2	11572-120E6	11.65	3.45	7.33	1.29	2.16	0.43	0.00	0.00
Fibroblast - Choroid Plexus, donor3	11653-122E6	26.37	7.32	8.79	1.46	1.46	0.00	0.00	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	15.91	12.92	5.30	1.15	1.15	0.23	0.00	0.00
Fibroblast - Conjunctival, donor3	11692-122I9	58.68	42.91	32.06	10.35	3.39	3.90	0.00	0.00
Fibroblast - Dermal, donor1	11269-116G9	30.76	10.57	10.33	4.23	0.94	1.17	0.00	0.00
Fibroblast - Dermal, donor2	11346-117G5	26.41	7.55	8.02	3.77	1.42	0.47	0.00	0.00
Fibroblast - Dermal, donor3	11418-118F5	23.69	11.00	7.13	3.51	1.69	0.60	0.00	0.00
Fibroblast - Dermal, donor4	11450-119A1	11.42	7.12	5.65	1.70	1.02	0.68	0.00	0.00
Fibroblast - Dermal, donor5	11454-119A5	12.04	6.28	2.62	2.44	0.70	0.35	0.00	0.00
Fibroblast - Dermal, donor6	11458-119A9	13.48	6.17	4.06	0.65	0.81	0.32	0.00	0.16
Fibroblast - Gingival, donor1	11237-116D4	37.27	22.91	10.41	3.96	2.50	1.04	0.00	0.00
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	18.86	8.38	9.69	4.45	0.79	1.57	0.00	0.00
Fibroblast - Gingival, donor2	11318-117D4	16.60	15.02	5.14	2.90	0.53	0.92	0.00	0.13
Fibroblast - Gingival, donor3	11394-118C8	25.53	17.11	8.90	5.03	1.64	1.16	0.00	0.10
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	20.78	4.16	9.35	6.23	0.00	2.08	0.00	0.00
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	8.99	3.35	7.05	1.59	0.88	0.53	0.00	0.18
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	18.86	9.67	6.86	2.96	1.40	1.71	0.00	0.16
Fibroblast - Gingival, donor6 (control)	11922-125H5	22.58	11.09	6.76	4.46	0.54	0.81	0.00	0.00
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	19.06	8.12	8.12	3.18	0.71	0.00	0.00	0.00
Fibroblast - Gingival, donor7 (control)	11924-125H7	16.96	8.48	7.60	2.19	1.02	0.88	0.00	0.00
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	23.59	13.50	8.73	4.91	1.23	0.41	0.00	0.00
Fibroblast - Gingival, donor8 (control)	11926-125H9	8.99	4.50	6.69	2.19	0.55	0.77	0.00	0.22
Fibroblast - Gingival, donor9 (control)	11927-125I1	12.33	5.87	9.98	4.40	2.79	0.44	0.00	0.00
Fibroblast - Lung, donor1	11270-116H1	10.87	4.08	5.44	1.36	0.00	0.00	0.00	0.00
Fibroblast - Lung, donor2	11347-117G6	20.89	17.91	5.97	2.98	0.00	2.98	0.00	0.00
Fibroblast - Lung, donor3	11419-118F6	17.09	8.86	3.38	2.95	0.42	0.42	0.00	0.21
Fibroblast - Lymphatic, donor1	11506-119G3	83.30	41.65	14.16	8.33	0.83	0.83	0.00	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	34.97	9.79	5.59	4.20	0.00	0.00	0.00	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	24.63	13.71	5.60	3.08	0.84	0.28	0.00	0.00
Fibroblast - Mammary, donor1	11540-120B1	54.81	32.07	19.89	6.09	2.84	1.62	0.00	0.00
Fibroblast - Mammary, donor2	11620-122A9	19.97	0.00	3.99	11.98	3.99	0.00	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	5.96	5.96	17.87	11.91	5.96	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	13.77	12.41	7.37	1.55	1.16	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor2	11319-117D5	16.69	10.77	3.49	3.19	1.21	0.30	0.00	0.00
Fibroblast - Periodontal Ligament, donor3	11395-118C9	42.84	20.20	12.55	4.28	1.22	1.22	0.00	0.00
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	17.55	9.16	8.01	4.96	1.91	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	11.61	3.51	5.94	5.40	0.81	1.62	0.00	0.27
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	12.06	4.99	7.19	3.02	0.81	0.35	0.00	0.12
Fibroblast - Pulmonary Artery, donor1	11250-116E8	31.61	15.92	10.50	4.31	1.33	2.10	0.00	0.11
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	31.90	16.66	8.33	4.06	1.63	0.41	0.20	0.00
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	21.38	15.37	6.68	5.35	0.00	2.00	0.00	0.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	20.95	16.21	8.70	4.35	1.58	0.79	0.00	0.00
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	33.74	9.13	15.48	5.36	1.59	1.79	0.00	0.20
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	15.45	6.04	11.19	2.66	1.42	1.60	0.00	0.00
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	16.36	7.49	9.26	3.55	1.38	1.58	0.00	0.39
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	45.13	10.83	21.66	9.63	2.41	2.11	0.00	0.00
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	30.55	10.58	15.22	5.51	1.30	1.73	0.00	0.00
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	15.94	3.04	7.09	1.27	1.01	0.51	0.00	0.00
Fibroblast - skin normal, donor1	11553-120C5	25.27	9.02	11.32	6.23	1.97	2.13	0.00	0.00
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	53.33	23.46	14.64	4.41	1.60	1.80	0.00	0.00
Fibroblast - skin normal, donor2	11561-120D4	24.81	12.06	8.54	3.42	1.21	1.41	0.00	0.00
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	27.20	6.04	9.07	3.32	0.60	0.30	0.00	0.00
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	14.08	4.97	10.69	3.23	1.24	0.83	0.00	0.08
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	29.23	18.12	13.33	5.81	1.71	0.85	0.00	0.00
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	53.53	12.15	21.68	6.90	1.31	2.96	0.00	0.00
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	31.21	13.63	11.08	3.09	1.28	1.38	0.00	0.00
Fibroblast - skin walker warburg, donor1	11554-120C6	23.95	11.30	6.41	3.54	0.84	0.17	0.00	0.00
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	22.43	12.08	7.21	6.59	0.94	1.57	0.00	0.16
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	66.48	0.00	22.16	0.00	0.00	0.00	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	392.19	40.96	14.82	20.92	2.61	1.74	0.87	0.00
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	257.96	25.83	10.23	9.88	1.91	0.87	0.52	0.52
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	365.38	33.83	11.97	8.33	1.56	1.56	0.26	0.26
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	272.12	24.27	6.64	9.20	2.04	1.28	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	28.33	12.25	6.12	1.53	0.00	0.00	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	42.75	13.40	3.83	1.28	0.64	0.00	0.00	0.64
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	42.79	17.12	2.85	1.71	1.43	1.14	0.00	0.29
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	16.82	7.17	8.00	2.76	1.93	0.83	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	15.75	5.02	8.45	1.37	2.05	1.14	0.00	0.23
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	34.47	12.68	3.76	3.17	1.39	0.40	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	17.45	6.87	6.61	2.38	0.79	0.53	0.00	0.26
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	12.07	6.20	4.24	1.96	1.63	0.98	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	29.19	7.52	1.77	0.88	1.77	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	52.15	20.49	2.97	4.80	2.40	1.13	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	47.29	15.64	6.16	3.08	2.46	1.60	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	48.89	19.07	4.57	4.57	1.88	0.81	0.00	0.81
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	33.70	12.14	5.45	3.22	1.61	0.99	0.50	0.37
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	42.91	15.23	4.29	4.71	1.52	0.69	0.00	0.14
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	38.42	13.62	2.24	3.25	0.20	0.41	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	59.55	20.08	10.95	5.93	1.83	1.14	0.23	0.23
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	41.98	17.44	4.86	2.12	1.37	0.50	0.37	0.25
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	44.15	21.64	3.72	3.28	1.53	0.66	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	56.73	12.11	13.00	6.21	1.77	3.25	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	42.12	12.72	7.15	3.50	1.91	0.64	0.00	0.16
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	58.76	12.73	5.36	4.02	1.56	1.12	0.22	0.22
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	47.38	13.91	13.11	8.27	2.62	1.21	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	37.83	10.69	5.94	6.62	2.54	1.36	0.00	0.17
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	95.23	20.84	13.21	7.36	2.31	0.80	0.35	0.18
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	99.06	30.38	21.75	10.20	5.20	2.39	0.00	0.21
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	76.34	22.54	26.47	7.34	5.12	3.42	0.00	0.17
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	54.11	18.37	8.30	6.53	2.88	1.66	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	104.74	20.05	12.73	7.74	3.33	1.83	0.00	0.08
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	87.39	20.21	10.62	4.90	1.63	1.63	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	54.88	18.15	14.65	6.81	2.68	4.13	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	49.23	16.26	12.91	5.07	3.00	0.69	0.00	0.12
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	88.22	17.51	12.34	7.67	2.84	2.84	0.00	0.67
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	63.48	24.25	12.12	10.58	1.76	1.54	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	63.46	20.91	17.22	8.12	4.30	1.97	0.00	0.37
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	96.61	16.21	13.78	7.46	4.05	1.13	0.00	0.32
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	64.14	19.24	20.85	13.47	7.38	3.53	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	61.02	18.95	10.33	6.44	2.84	1.42	0.00	0.28
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	125.28	22.62	15.50	10.12	3.16	2.85	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	65.07	23.41	16.72	13.99	3.34	4.56	0.00	0.61
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	55.51	15.79	10.87	6.17	2.30	1.57	0.00	0.10
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	165.98	23.93	17.13	16.69	3.51	3.07	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	71.54	18.52	16.83	11.22	5.61	3.09	0.00	0.28
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	55.74	16.94	8.06	3.70	1.02	0.74	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	122.20	25.67	10.70	9.89	2.14	0.80	0.00	0.27
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	84.92	20.04	11.93	6.43	1.99	1.22	0.00	0.15
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	70.34	17.10	6.09	4.40	1.30	1.04	0.00	0.39
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	223.64	25.21	14.64	15.18	4.88	3.25	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	79.82	20.28	11.25	8.30	1.66	2.03	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	63.82	17.11	18.86	8.33	3.73	2.19	0.00	0.22
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	279.67	37.69	25.79	36.69	8.93	6.94	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	61.87	13.85	14.11	6.20	2.77	1.85	0.00	0.13
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	40.55	14.93	12.91	6.46	2.02	1.82	0.00	0.81
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	338.54	66.84	71.67	35.58	19.82	11.44	0.00	0.00
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	67.28	27.07	6.97	4.38	1.19	0.60	0.00	0.20
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	49.92	20.18	7.09	6.32	1.85	0.62	0.00	0.15
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	35.60	18.00	4.30	2.66	2.05	0.82	0.00	0.20
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	30.98	10.64	5.01	3.44	0.94	0.63	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	37.86	11.58	3.67	2.54	0.85	0.57	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	35.05	10.15	8.30	3.69	1.84	0.92	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	51.97	12.37	0.00	2.47	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	33.27	8.51	5.03	5.42	1.16	0.00	0.00	0.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	27.28	4.81	6.42	3.21	1.60	3.21	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	31.30	10.43	5.22	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	29.62	9.44	4.56	2.60	0.65	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	38.71	7.82	3.29	3.71	0.41	0.82	0.00	0.41
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	19.99	6.66	3.33	6.66	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	30.76	6.71	1.96	1.96	0.84	1.12	0.00	0.28
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	38.24	8.82	2.94	4.90	0.33	1.63	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	23.49	10.07	2.52	0.84	0.00	0.00	0.00	0.84
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	43.26	9.86	5.41	3.50	1.59	0.95	0.00	0.64
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	26.15	5.77	2.38	3.06	0.34	0.68	0.00	0.34
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	35.50	10.44	0.00	2.09	2.09	2.09	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	33.22	8.02	5.73	3.44	1.15	0.57	0.00	0.57
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	29.01	10.95	4.44	2.37	1.78	2.07	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	25.41	6.78	6.78	3.39	0.00	1.69	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	34.79	8.28	4.56	3.73	1.24	1.66	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	28.77	6.67	7.82	3.45	0.69	2.07	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	10.54	10.54	0.00	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	28.45	6.92	3.84	3.84	1.15	0.38	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	31.29	8.48	1.96	1.30	1.30	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	23.41	6.02	1.34	0.67	0.67	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	36.99	9.63	10.79	3.47	3.47	1.16	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	42.45	7.19	8.90	2.05	2.40	0.68	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	9.94	2.48	4.97	2.48	7.45	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	24.06	9.44	9.91	1.89	4.72	0.94	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	36.21	6.03	5.43	2.41	4.83	0.60	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	21.87	9.16	12.21	2.03	2.54	2.03	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	31.91	7.58	10.37	4.39	2.39	1.20	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	29.60	12.83	10.85	3.95	1.48	0.49	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	33.05	9.44	5.90	7.08	3.54	1.18	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	30.34	8.75	6.42	5.83	1.75	1.17	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	35.11	6.58	7.46	2.19	1.32	0.88	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	22.89	10.17	4.24	1.70	0.00	2.54	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	40.59	4.78	8.95	2.39	2.39	1.79	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	30.57	5.82	7.28	2.43	1.46	1.46	0.00	0.49
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	19.40	5.71	5.71	1.14	0.00	0.00	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	20.79	5.41	6.24	3.33	0.00	2.08	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	25.86	9.00	6.75	1.12	0.00	0.00	0.00	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	31.72	15.86	13.32	6.34	1.59	1.90	0.00	0.00
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	52.22	26.32	21.30	8.77	1.67	2.51	0.00	0.00
Hep-2 cells mock treated, biol_rep1	11898-125E8	38.41	12.07	3.71	3.37	0.46	0.46	0.00	0.12
Hep-2 cells mock treated, biol_rep2	11899-125E9	29.71	8.10	3.04	2.87	0.51	0.17	0.00	0.17
Hep-2 cells mock treated, biol_rep3	11900-125F1	31.85	10.01	1.82	2.28	0.23	0.23	0.00	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	35.63	12.68	3.61	3.94	0.66	0.44	0.00	0.11
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	33.10	14.83	3.87	3.01	0.00	0.43	0.00	0.21
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	31.22	11.19	3.01	3.88	0.22	0.00	0.00	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	37.73	12.08	3.99	3.24	0.62	0.00	0.00	0.25
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	32.42	8.58	4.46	2.92	0.34	0.00	0.00	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	23.39	8.01	0.32	2.24	0.32	0.00	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	41.97	16.23	6.72	5.04	1.68	3.92	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	25.10	4.33	9.95	5.19	0.43	1.73	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	37.01	7.93	15.86	10.58	0.00	2.64	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	54.32	26.81	9.52	4.59	1.76	1.41	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	37.78	19.62	9.44	5.09	0.73	0.73	0.00	0.73
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	18.01	9.79	5.77	2.80	0.52	0.35	0.00	0.00
Hepatocyte, donor1	11523-119I2	33.90	9.68	4.84	2.42	2.42	1.21	0.00	0.00
Hepatocyte, donor2	11603-120I1	26.93	10.77	2.15	3.23	1.08	0.00	0.00	0.00
Hepatocyte, donor3	11684-122I1	30.06	13.50	7.98	3.07	0.61	1.84	0.00	0.00
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	0.65	0.65	0.65	0.00	0.65	0.00	216.69	0.65
Intestinal epithelial cells (polarized), donor1	11246-116E4	74.11	12.76	11.54	7.52	3.50	1.22	0.00	0.00
Iris Pigment Epithelial Cells, donor1	11530-119I9	39.10	13.86	8.51	2.06	1.51	1.10	0.00	0.14
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	3.18	3.18	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	13.35	13.35	6.68	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	2.77	1.38	0.00	1.38	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	2.50	2.50	2.50	0.00	2.50	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	11.87	23.74	0.00	11.87	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	5.13	0.00	0.00	2.56	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	0.00	9.14	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	6.50	3.25	1.62	0.00	0.00	0.00	1.62	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	5.00	1.67	1.67	0.00	1.67	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	3.63	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	1.32	3.97	0.00	1.32	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	3.33	2.22	3.33	0.00	1.11	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	0.00	5.24	0.00	5.24	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	4.41	4.41	2.52	0.63	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	1.55	4.64	0.00	1.55	3.09	0.00	1.55	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	2.58	0.65	0.65	0.00	0.65	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	3.22	1.61	4.83	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	5.70	6.52	1.63	0.00	0.00	0.81	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	5.04	4.20	1.68	0.42	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	4.02	2.41	1.61	0.80	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	6.46	2.77	1.85	0.92	0.00	0.92	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	0.00	15.08	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	5.66	1.89	1.42	0.94	0.94	0.00	0.47	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	4.53	1.81	0.91	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	29.48	0.00	14.74	14.74	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	5.38	4.30	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	6.35	5.08	1.27	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	2.55	3.19	1.91	0.64	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	3.65	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	3.57	2.86	2.14	0.00	0.71	0.71	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	0.00	0.00	3.32	3.32	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	20.85	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	1.54	3.09	1.23	0.00	0.31	0.31	0.00	0.31
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	7.02	0.00	3.51	0.00	1.76	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	6.29	3.14	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	7.65	2.09	0.70	1.39	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	0.00	2.21	2.21	0.00	0.00	2.21	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	9.73	3.24	3.24	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	6.10	7.85	1.74	2.62	0.87	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	0.00	4.50	4.50	2.25	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	0.00	13.94	0.00	3.48	0.00	3.48	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	7.47	3.20	2.13	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	2.77	2.77	1.39	1.39	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	8.55	0.00	0.00	2.85	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	3.68	3.68	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	3.03	9.08	6.05	3.03	3.03	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	6.21	6.21	6.21	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	7.40	1.06	0.00	0.00	2.11	1.06	0.00	0.00
Keratinocyte - epidermal, donor1	11272-116H3	525.58	55.32	21.13	26.85	4.73	2.37	0.00	0.16
Keratinocyte - epidermal, donor2	11349-117G8	115.37	11.71	5.86	5.86	1.17	1.17	0.00	0.00
Keratinocyte - epidermal, donor3	11421-118F8	137.82	23.76	6.82	9.37	1.61	0.47	0.00	0.19
Keratinocyte - oral, donor1	11251-116E9	466.78	72.65	18.05	27.47	10.78	1.70	0.00	0.34
Keratocytes, donor1	11527-119I6	10.66	6.88	9.28	2.75	1.38	1.38	0.00	0.00
Keratocytes, donor2	11607-120I5	23.44	17.58	2.34	0.00	1.17	0.00	0.00	0.00
Keratocytes, donor3	11688-122I5	20.35	6.13	9.68	4.74	2.57	0.99	0.00	0.20
Krukenberg tumor cell line:HSKTC	10687-109F3	0.00	0.00	2.20	0.00	0.00	0.00	0.00	0.00
Lens Epithelial Cells, donor1	11529-119I8	14.02	5.39	5.39	2.16	1.08	1.08	0.00	0.00
Lens Epithelial Cells, donor2	11609-120I7	42.56	12.69	29.76	4.04	8.30	6.11	0.00	0.12
Lens Epithelial Cells, donor3	11690-122I7	24.32	8.78	9.38	2.62	2.22	1.72	0.00	0.10
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	36.40	11.15	8.06	5.57	2.25	0.95	0.00	0.24
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	35.72	6.70	9.77	4.19	0.56	1.67	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	34.63	10.23	5.98	5.19	1.26	0.94	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	35.49	8.60	6.99	3.23	1.61	0.54	0.00	0.54
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	32.78	9.45	6.93	3.15	2.21	1.89	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	24.69	8.95	5.71	3.02	0.97	0.43	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	25.44	6.16	4.92	2.87	1.64	1.23	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	36.41	11.63	11.38	6.07	0.76	2.02	0.00	0.25
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	29.70	7.88	8.30	3.66	1.27	0.84	0.00	0.14
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	37.18	9.89	5.14	5.14	0.79	0.79	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	34.90	10.08	10.86	3.49	1.74	1.16	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	27.96	7.59	4.44	3.33	0.74	0.37	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	34.49	8.71	5.23	5.57	0.35	1.74	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	38.40	12.64	11.93	4.05	1.67	1.43	0.00	0.24
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	27.47	10.71	4.94	4.94	1.51	0.41	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	34.49	10.78	7.08	4.62	1.23	0.92	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	26.19	9.98	10.60	4.99	0.00	2.18	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	32.21	9.70	6.40	5.31	1.10	0.18	0.00	0.18
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	31.92	9.54	5.92	3.62	0.99	0.99	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	29.29	10.25	9.96	2.34	0.59	0.88	0.29	0.59
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	26.64	11.45	9.71	5.97	0.25	0.50	0.00	0.25
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	32.01	11.15	6.79	1.94	1.45	0.48	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	32.58	7.81	8.08	5.92	1.35	0.81	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	26.49	9.23	7.27	4.24	0.61	0.45	0.00	0.30
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	28.51	7.78	8.81	4.67	0.52	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	30.15	11.10	8.79	3.14	0.63	0.84	0.00	0.21
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	26.77	7.22	4.66	2.71	1.65	0.60	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	34.39	11.01	3.44	3.44	0.00	1.38	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	35.18	12.04	8.09	2.82	1.13	1.32	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	28.63	7.74	6.15	3.71	1.27	0.11	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	41.19	7.27	6.30	5.33	0.48	0.48	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	34.73	11.58	7.61	3.31	0.66	2.32	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	36.92	11.65	7.19	5.70	1.49	0.62	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	42.57	11.11	10.00	4.07	0.74	0.74	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	37.80	11.37	8.65	3.71	0.49	0.74	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	28.60	9.76	6.32	4.40	0.41	0.69	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	38.92	8.36	6.11	4.50	0.96	0.32	0.00	0.32
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	31.95	10.65	10.65	4.56	1.22	1.22	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	31.63	11.34	5.88	4.62	0.70	1.40	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	31.29	7.47	6.76	4.98	1.07	0.71	0.00	0.36
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	34.42	15.03	9.21	5.33	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	29.72	10.89	6.85	3.89	1.24	0.47	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	33.30	11.46	6.80	3.58	1.07	0.36	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	43.12	11.43	13.07	3.59	2.29	1.31	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	28.02	9.42	6.83	4.00	1.65	0.71	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	44.30	14.60	9.03	5.69	1.73	1.11	0.00	0.12
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	32.53	8.71	7.43	1.54	1.02	0.77	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	20.88	5.97	5.37	2.39	0.90	1.49	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	11.33	2.27	0.00	6.80	0.00	2.27	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	20.71	3.07	6.14	3.07	0.77	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	21.52	5.94	4.45	1.48	0.74	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	24.12	3.81	5.50	4.23	1.27	1.27	0.00	0.42
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	23.91	1.41	4.22	3.52	0.00	0.70	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	24.28	4.67	1.87	0.93	0.00	0.93	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	15.97	5.67	4.12	3.61	0.00	1.03	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	19.03	1.19	4.76	1.19	1.19	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	23.98	6.56	6.56	3.85	0.45	1.81	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	21.52	6.11	6.11	3.49	0.87	1.16	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	24.76	4.05	3.60	3.15	0.45	1.35	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	33.87	5.01	7.32	2.44	1.08	1.22	0.00	0.14
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	22.60	6.16	8.22	4.62	2.05	1.54	0.00	0.51
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	27.52	3.53	6.00	1.41	0.00	1.06	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	21.99	1.33	6.00	1.33	0.00	2.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	20.88	3.06	4.58	1.53	1.02	1.02	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	25.88	6.67	5.60	3.20	0.53	2.13	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	19.84	5.67	5.48	3.40	0.94	0.76	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	21.47	3.68	4.29	3.68	1.23	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	24.46	5.71	6.52	1.63	0.00	0.82	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	24.36	3.54	8.33	3.12	0.00	0.62	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	21.86	3.36	8.41	2.80	1.12	0.28	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	24.73	4.12	4.12	0.00	2.06	1.03	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	24.97	4.94	5.52	2.03	0.29	0.58	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	23.62	5.38	4.78	2.09	0.90	0.90	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	23.79	3.87	7.75	1.66	1.11	0.55	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	21.56	4.24	3.53	2.83	1.06	0.71	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	23.97	2.95	7.01	1.84	0.00	0.37	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	20.72	1.15	5.76	2.30	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	23.41	6.52	6.52	0.77	1.54	0.77	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	26.04	5.10	5.66	2.83	0.57	0.57	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	18.87	2.46	4.92	4.10	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	21.24	5.42	7.23	1.36	1.81	0.45	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	24.42	8.62	7.18	2.87	0.72	0.72	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	32.12	5.23	2.99	2.99	0.75	0.75	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	19.69	5.95	6.69	3.34	0.74	0.37	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	24.12	4.74	5.60	2.15	0.86	0.43	0.00	0.43
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	38.53	3.43	2.57	1.71	0.86	0.86	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	27.99	2.33	6.33	3.00	1.33	0.33	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	23.53	7.24	4.22	3.02	0.60	0.60	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	24.17	1.42	7.11	0.71	0.71	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	22.69	4.12	4.12	2.06	1.03	0.69	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	24.69	4.83	4.29	2.68	0.00	1.07	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	21.55	2.02	5.39	0.67	1.35	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	25.93	5.19	6.67	3.70	2.22	0.37	0.00	0.37
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	24.42	3.49	6.98	2.33	1.16	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	20.10	0.00	5.29	1.06	0.00	0.00	0.00	1.06
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	19.21	2.40	4.00	4.00	0.80	0.40	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	18.17	3.63	3.63	2.18	1.45	0.73	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	16.10	2.30	5.37	4.60	0.77	1.53	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	20.22	3.95	5.43	2.47	0.00	0.49	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	23.52	4.70	3.76	3.76	0.94	0.94	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	22.12	3.02	5.03	3.02	0.00	0.50	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	21.18	4.06	5.41	2.70	1.35	1.35	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	18.93	5.16	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	28.95	2.67	4.90	3.56	1.34	0.00	0.00	0.45
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	22.68	3.91	5.87	2.74	0.78	1.17	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	18.47	5.28	3.30	3.30	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	18.68	5.71	4.67	1.04	1.04	1.04	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	25.38	3.50	4.38	3.94	1.31	0.44	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	24.04	2.80	1.68	3.91	0.56	0.56	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	22.08	6.18	6.18	2.65	1.77	1.32	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	22.76	2.31	6.56	2.70	0.77	0.77	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	18.23	5.57	4.56	2.53	1.01	0.51	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	18.74	3.36	6.25	1.44	0.96	0.48	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	19.88	2.39	3.98	1.99	0.80	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	25.52	7.90	4.25	1.82	1.22	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	23.52	8.30	2.08	1.38	0.69	1.38	0.00	0.69
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	20.90	1.90	4.94	3.04	1.52	2.66	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	16.53	3.10	4.65	3.61	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	23.58	6.05	5.44	3.02	1.21	1.81	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	22.82	4.44	3.49	2.22	1.27	0.63	0.00	0.32
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	17.59	4.80	5.33	2.13	1.07	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	28.73	1.72	2.87	2.30	0.00	0.57	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	22.11	2.06	5.66	2.06	0.00	1.03	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	26.17	2.12	7.78	1.41	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	30.64	4.54	5.11	3.97	1.70	1.13	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	22.47	4.58	2.91	4.16	1.25	1.25	0.00	0.42
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	19.58	3.92	5.48	2.35	0.00	1.57	0.00	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	30.90	3.34	6.26	0.42	0.84	1.67	0.00	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	19.51	3.72	8.36	3.25	1.86	0.00	0.00	0.46
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	20.74	5.35	4.68	2.68	0.67	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	37.42	5.35	4.81	4.28	1.07	1.07	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	21.42	2.83	6.47	2.42	0.40	0.81	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	30.29	5.51	4.59	6.42	0.00	0.92	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	24.90	2.67	8.89	4.45	1.78	0.89	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	23.36	3.42	3.42	2.85	1.71	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	20.71	5.37	4.60	4.60	0.77	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	38.85	6.57	8.75	2.19	0.55	1.64	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	23.61	4.01	4.01	3.12	0.00	0.89	0.00	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	34.05	4.94	7.80	3.38	1.04	0.52	0.00	0.26
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	38.46	5.97	4.64	2.65	0.00	0.66	0.00	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	43.65	6.24	10.39	8.31	4.16	0.00	0.00	0.00
Macrophage - monocyte derived, donor1	11232-116C8	1616.15	60.63	54.70	44.67	6.61	7.29	0.00	0.68
Macrophage - monocyte derived, donor2	11313-117C8	4872.48	29.73	29.18	33.03	7.34	3.12	0.00	4.40
Macrophage - monocyte derived, donor3	11389-118C3	2560.93	34.61	33.56	36.83	6.42	2.88	0.00	4.46
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	136.47	13.81	6.90	9.03	0.53	1.06	0.53	0.00
Mallassez-derived cells, donor2	11929-125I3	188.08	36.29	11.41	12.20	1.74	0.16	0.00	0.48
Mallassez-derived cells, donor3	11930-125I4	302.16	30.02	12.51	17.37	1.95	1.53	0.28	0.14
Mammary Epithelial Cell, donor1	11273-116H4	151.96	27.60	7.57	6.98	2.39	0.60	0.00	0.00
Mammary Epithelial Cell, donor2	11350-117G9	302.00	42.27	12.16	17.37	2.32	1.45	0.00	0.29
Mammary Epithelial Cell, donor3	11422-118F9	94.03	17.96	5.74	6.98	0.75	0.50	0.00	0.50
Mast cell - stimulated, donor1	11487-119E2	576.92	60.34	72.54	87.45	6.78	9.49	0.00	0.68
Mast cell, donor1	11563-120D6	751.36	59.37	58.18	19.36	7.68	9.19	0.00	0.32
Mast cell, donor2	11565-120D8	393.76	81.13	89.75	29.72	8.92	7.43	0.00	1.19
Mast cell, donor3	11566-120D9	393.52	80.37	53.80	31.97	10.36	6.75	0.00	0.68
Mast cell, donor4	11567-120E1	302.81	62.05	52.30	20.92	7.09	5.50	0.00	0.53
Mast cell, expanded and stimulated, donor5	11940-126A5	996.04	72.75	77.51	60.10	7.65	13.75	0.22	0.67
Mast cell, expanded and stimulated, donor8	11942-126A7	242.81	33.27	28.60	14.59	2.33	3.50	0.00	0.00
Mast cell, expanded, donor5	11939-126A4	767.72	74.11	67.23	43.71	7.00	10.90	0.00	0.80
Mast cell, expanded, donor8	11941-126A6	290.55	45.19	22.76	19.08	2.18	3.35	0.00	0.84
Melanocyte - dark, donor1	11502-119F8	25.37	19.30	5.07	2.29	0.90	0.50	0.00	0.00
Melanocyte - dark, donor2	11582-120F7	23.88	21.11	5.54	2.77	0.35	0.69	0.00	0.00
Melanocyte - dark, donor3	11663-122F7	164.51	28.54	24.85	9.78	5.07	2.68	0.00	0.07
Melanocyte - light, donor1	11274-116H5	100.61	23.04	13.87	7.76	2.82	2.59	0.00	0.24
Melanocyte - light, donor2	11351-117H1	130.35	25.25	8.19	6.82	2.05	1.36	0.00	0.00
Melanocyte - light, donor3	11423-118G1	40.76	18.21	11.27	6.07	0.00	1.73	0.00	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	86.22	16.45	14.89	9.16	2.29	1.56	0.00	0.31
Melanocyte, donor2 (MC+2)	12739-135I3	229.68	36.31	16.14	16.41	2.69	1.61	0.00	0.54
Melanocyte, donor3 (MC+3)	12837-137B2	417.85	39.11	27.32	31.61	6.70	4.29	0.00	1.07
Meningeal Cells, donor1	11493-119E8	52.60	28.04	11.17	4.22	2.23	2.23	0.00	0.00
Meningeal Cells, donor2	11573-120E7	29.93	12.32	5.28	1.32	2.20	0.88	0.00	0.00
Meningeal Cells, donor3	11654-122E7	31.79	17.77	11.57	4.97	1.14	1.06	0.00	0.08
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	28.52	23.95	7.98	2.28	1.71	0.86	0.00	0.00
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	42.47	8.65	8.55	6.64	0.91	1.01	0.00	0.00
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	42.05	52.57	18.40	5.26	2.63	6.57	0.00	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	15.70	14.39	3.92	3.92	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	15.79	12.92	5.02	3.59	0.72	1.44	0.00	0.00
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	23.72	11.44	7.62	3.60	1.27	0.85	0.00	0.00
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	22.62	9.05	8.54	4.02	1.01	0.50	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	35.82	24.17	12.53	3.30	2.64	0.88	0.00	0.22
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	19.00	12.42	5.11	2.92	0.73	1.46	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	21.69	13.91	6.75	4.91	0.82	1.43	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	48.89	25.21	22.44	6.37	4.57	3.32	0.00	0.14
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	43.86	22.30	12.27	4.09	2.23	1.49	0.00	0.37
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	38.16	18.68	13.29	7.37	3.16	2.24	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	53.71	12.46	16.32	5.34	1.48	1.78	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	21.02	0.00	11.68	4.67	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	34.58	24.34	10.25	2.56	0.64	1.28	0.00	0.00
Mesenchymal stem cells - adipose, donor0	11217-116B2	18.79	18.79	9.92	2.48	0.71	1.77	0.00	0.00
Mesenchymal stem cells - hepatic, donor0	11218-116B3	32.21	16.89	15.32	5.00	3.75	0.63	0.00	0.00
Mesenchymal stem cells - umbilical, donor0	11214-116A8	17.42	5.08	10.16	5.08	0.00	2.18	0.00	0.00
Mesothelial Cells, donor1	11247-116E5	118.53	16.44	13.26	6.89	1.59	3.45	0.00	0.27
Mesothelial Cells, donor2	12156-128G5	68.56	14.51	8.51	4.50	2.50	1.00	0.00	0.00
Mesothelial Cells, donor3	11402-118D7	49.00	9.68	9.83	3.90	0.87	1.23	0.00	0.14
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	3659.38	31.06	21.61	36.46	2.70	0.00	0.00	2.70
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	5069.07	45.81	39.90	61.57	6.65	6.65	0.00	7.63
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	7055.53	42.40	31.51	48.59	3.53	4.42	0.00	5.59
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	1863.37	31.11	6.91	34.57	6.91	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	3449.09	39.98	28.52	51.45	4.65	3.41	0.00	5.89
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	6084.63	37.75	34.85	42.32	4.56	4.56	0.00	3.94
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	1303.94	9.26	4.63	16.21	4.63	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	4304.50	38.54	31.03	55.31	7.26	4.25	0.00	8.51
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	6430.14	43.76	29.79	45.62	4.19	4.65	0.00	4.65
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	914.91	19.47	0.00	19.47	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	4261.43	40.64	37.59	56.90	5.08	3.86	0.00	8.54
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	5838.87	39.99	27.32	49.10	6.73	3.96	0.00	6.73
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	923.56	8.55	0.00	25.65	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	4367.17	53.10	42.48	64.60	9.73	3.54	0.00	13.27
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	6515.54	49.39	36.09	47.49	4.94	5.32	0.00	4.94
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	1240.90	5.26	3.95	19.74	2.63	2.63	0.00	1.32
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	3983.24	40.96	40.11	66.43	6.58	6.79	0.00	9.55
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	2731.17	16.57	17.50	16.57	0.92	3.68	0.00	0.92
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	3260.13	29.51	31.00	54.84	5.96	2.98	0.00	3.28
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	2231.66	13.41	11.74	16.77	1.68	1.68	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	848.73	33.95	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	3150.84	32.37	30.61	56.45	6.77	5.77	0.00	10.04
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	5271.23	28.52	32.56	33.51	4.28	3.57	0.00	3.57
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	1636.53	11.61	9.40	22.67	0.00	1.11	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	3305.64	30.16	32.93	52.73	3.45	3.68	0.00	7.37
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	5383.00	33.02	30.29	42.49	6.10	3.58	0.00	5.47
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	2786.94	22.01	19.98	41.99	5.50	0.82	0.00	3.67
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	3605.11	39.90	37.97	56.42	5.79	4.08	0.00	7.51
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	4792.81	27.56	22.01	34.23	3.33	1.78	0.00	3.11
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	629.43	20.64	10.32	20.64	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	3097.12	26.94	33.73	46.43	5.69	5.26	0.00	5.91
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	3472.65	23.32	16.73	30.42	2.03	2.53	0.00	1.01
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	1148.30	16.57	3.31	9.94	0.00	1.66	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	3080.22	26.36	32.34	55.17	5.71	4.08	0.00	5.16
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	4905.59	27.35	26.47	44.99	2.65	2.35	0.00	2.35
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	1211.35	8.72	10.90	23.99	0.00	0.00	0.00	2.18
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	3257.20	22.11	37.48	60.55	4.32	3.84	0.00	7.21
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	4628.65	32.42	21.21	37.22	5.60	2.00	0.00	4.00
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	1099.72	8.23	16.45	20.57	0.00	1.37	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	3187.18	25.03	33.54	59.57	3.50	4.51	0.00	9.01
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	6494.26	0.00	161.68	53.89	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	1190.48	12.23	12.23	10.19	2.04	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	3009.40	20.58	32.84	51.24	3.50	3.50	0.00	4.38
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	2094.73	11.04	18.76	16.55	0.00	0.00	0.00	1.10
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	1483.78	9.61	8.33	14.73	1.92	1.28	0.00	1.28
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	3130.47	22.31	33.47	48.59	2.98	4.96	0.00	3.97
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	2721.65	9.05	10.44	20.88	0.70	2.78	0.00	0.70
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	1383.38	0.00	6.63	4.42	2.21	2.21	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	2796.21	23.59	24.27	40.34	4.10	3.76	0.00	5.81
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	2665.51	16.19	9.63	17.07	1.31	2.63	0.00	1.75
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	1137.73	5.33	4.62	14.20	0.71	1.07	0.00	0.36
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	3173.60	19.92	22.16	36.19	5.61	3.93	0.00	5.33
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	3545.72	20.37	12.05	23.28	2.08	2.49	0.00	3.74
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	1163.74	1.75	5.83	13.40	2.91	0.58	0.00	0.58
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	2538.21	15.99	21.12	25.64	5.13	1.51	0.00	5.43
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	4438.95	26.71	11.69	25.46	5.43	2.09	0.00	11.27
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	1342.70	7.22	7.22	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	1923.76	17.55	13.85	35.10	0.92	5.54	0.00	6.46
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	4736.77	25.04	13.66	29.03	3.98	2.85	0.00	5.69
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	2010.26	13.40	10.64	18.10	1.80	1.24	0.00	2.21
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	2557.28	15.81	20.73	32.91	5.96	3.37	0.00	5.18
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	4488.38	21.88	16.73	30.89	4.29	4.29	0.00	3.00
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	1149.06	5.08	5.08	12.07	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	1710.49	9.87	13.61	22.69	1.33	1.87	0.00	1.07
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	4418.70	27.84	23.65	28.14	4.19	2.39	0.00	5.39
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	1598.71	11.87	11.16	17.66	2.40	1.41	0.00	2.83
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	2316.23	13.38	16.88	27.07	1.91	2.87	0.00	3.82
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	5368.61	21.01	17.25	34.28	3.54	3.54	0.00	4.20
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	1560.41	8.34	11.00	14.79	3.79	0.38	0.00	1.14
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	2264.61	11.65	17.05	26.42	3.13	2.56	0.00	2.84
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	5722.55	28.02	24.09	37.61	6.39	3.93	0.25	6.88
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	948.18	5.21	9.12	7.82	0.65	1.30	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	2070.84	14.11	21.76	27.93	5.00	1.18	0.00	4.70
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	4425.23	22.49	18.74	29.99	4.32	2.31	0.00	7.21
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	2547.05	21.84	21.43	32.56	3.30	3.71	0.00	2.89
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	2021.05	13.70	19.95	22.63	3.28	2.68	0.00	2.98
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	1329.71	22.60	26.37	45.20	0.00	0.00	0.00	3.77
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	2473.76	26.73	42.77	71.29	12.48	3.56	0.00	8.91
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	2811.26	44.03	42.71	64.07	5.59	8.21	0.00	5.91
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	2451.05	38.92	42.08	39.97	3.16	2.10	0.00	7.36
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	3607.58	56.34	39.93	59.90	6.92	4.35	0.00	5.14
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	4662.20	38.18	53.09	93.13	14.90	10.24	0.00	7.45
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	2794.31	51.07	57.83	61.21	6.01	7.14	0.00	5.63
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	4844.51	39.95	37.29	60.99	10.92	7.72	0.00	7.46
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	1621.87	32.57	27.48	39.36	4.52	3.62	0.00	1.36
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	2896.80	25.05	50.10	65.57	7.37	6.63	0.00	5.89
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	2529.79	37.38	45.80	58.99	3.30	6.60	0.00	7.33
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	2485.84	51.33	40.45	59.11	3.11	6.22	0.00	17.11
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	633.84	8.02	6.41	6.41	0.53	1.60	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	1738.76	11.59	23.18	54.09	0.00	3.86	0.00	7.73
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	2649.07	39.39	45.45	69.69	8.08	3.03	0.00	5.05
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	1407.43	15.60	17.71	21.93	1.26	2.53	0.00	2.11
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	416.75	4.09	5.45	5.45	1.36	4.09	0.00	4.09
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	392.29	3.81	5.72	5.72	1.91	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	274.53	4.86	4.05	7.29	0.00	2.43	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	474.28	1.51	3.02	6.04	0.00	0.00	0.00	1.51
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	748.03	11.42	0.00	5.71	5.71	5.71	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	1269.09	9.79	9.79	39.15	13.05	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	1330.69	9.50	9.50	14.26	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	414.12	0.00	0.00	12.55	0.00	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	24.56	8.83	9.05	4.96	2.80	1.72	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	16.20	11.50	9.93	4.70	2.09	2.09	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	39.38	22.69	11.35	4.00	1.33	1.33	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	25.04	15.44	0.42	2.09	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	26.43	17.11	11.41	6.85	1.33	1.33	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	23.94	12.77	7.98	1.60	0.00	1.60	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	26.52	11.56	10.88	6.80	1.36	0.00	0.00	0.68
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	27.56	0.00	5.51	7.35	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	39.34	10.46	9.63	5.44	1.26	0.84	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	33.70	15.34	6.74	3.49	0.23	0.70	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	33.51	16.21	10.81	5.67	0.81	1.89	0.00	0.54
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	23.97	11.98	9.04	3.99	1.26	2.31	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	33.40	22.27	11.13	33.40	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	57.08	22.83	10.92	5.96	0.99	0.00	0.00	0.50
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	35.19	14.35	9.20	9.74	1.62	0.54	0.00	0.27
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	43.07	11.79	5.44	5.89	0.91	0.23	0.00	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	25.80	11.10	10.29	3.43	1.80	1.80	0.00	0.00
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	34.45	11.12	13.49	7.29	0.91	2.55	0.00	0.55
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	46.68	20.16	12.20	8.49	1.06	2.12	0.00	0.00
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	41.42	19.21	18.61	6.60	1.80	1.20	0.00	1.20
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	57.43	22.32	19.03	13.78	1.31	1.64	0.00	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	28.62	9.11	6.99	6.34	0.81	0.49	0.00	0.33
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	34.39	9.52	13.41	6.35	1.23	1.76	0.00	0.00
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	33.76	10.55	11.95	2.81	0.70	1.41	0.00	0.70
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	37.70	15.63	11.03	4.14	0.92	1.38	0.00	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	35.67	9.32	11.89	5.14	0.96	0.96	0.00	0.64
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	43.46	13.45	10.35	10.00	1.38	0.34	0.00	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	32.87	5.06	17.70	7.59	0.00	2.53	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	24.06	8.02	12.70	5.35	1.34	1.56	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	26.25	7.62	6.35	5.93	1.27	1.69	0.00	0.42
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	29.67	12.58	11.39	5.93	0.71	1.19	0.00	0.47
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	19.75	9.01	4.72	5.15	0.43	0.43	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	36.11	0.00	18.06	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	25.99	10.00	10.66	7.00	3.00	3.00	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	10.82	1.80	7.66	4.51	1.80	0.90	0.00	0.45
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	13.89	4.36	6.75	1.98	1.19	0.40	0.00	0.40
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	21.36	7.43	6.50	4.64	0.93	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	23.84	9.84	9.84	6.43	1.14	0.76	0.00	0.76
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	17.27	4.24	5.54	4.56	0.33	0.65	0.00	0.33
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	21.79	6.10	13.95	2.61	1.31	0.87	0.00	0.44
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	19.90	4.07	7.69	1.81	0.90	1.36	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	21.17	10.58	4.41	3.53	0.00	1.76	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	18.62	7.98	15.96	8.64	1.99	0.66	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	32.74	11.41	15.87	2.98	1.98	1.98	0.00	0.50
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	16.08	4.59	3.83	3.06	1.15	0.38	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	38.41	11.80	24.80	12.70	3.02	3.02	0.00	0.30
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	16.36	5.53	8.84	3.32	1.77	1.55	0.00	0.22
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	16.94	8.13	11.52	2.71	0.68	1.36	0.00	0.00
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	20.44	0.00	5.11	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	27.44	15.85	10.36	1.83	0.61	2.44	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	15.74	4.09	5.67	1.89	0.31	0.94	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	27.24	12.71	14.83	6.36	1.51	2.42	0.00	0.30
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	15.82	7.12	5.54	3.96	0.79	0.79	0.00	0.79
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	29.47	10.20	19.27	11.34	0.00	3.40	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	30.35	0.00	10.12	10.12	0.00	0.00	0.00	0.00
Myoblast, donor1	11241-116D8	32.67	6.71	7.58	5.09	0.62	0.25	0.00	0.00
Myoblast, donor2	11322-117D8	28.58	12.27	10.16	4.79	1.73	1.15	0.00	0.19
Myoblast, donor3	11398-118D3	54.48	16.31	11.77	4.04	1.18	1.18	0.00	0.17
NK T cell leukemia cell line:KHYG-1	10777-110G3	24.81	6.28	4.67	3.06	1.02	0.29	2.19	0.00
Natural Killer Cells, donor1	11230-116C6	22.76	8.61	5.23	0.62	0.92	1.23	1.54	0.00
Natural Killer Cells, donor2	11311-117C6	5.43	3.32	2.71	1.51	0.30	0.30	2.11	0.00
Natural Killer Cells, donor3	11387-118C1	21.35	4.97	4.60	2.76	0.74	0.37	1.29	0.00
Neural stem cells, donor1	11275-116H6	36.29	7.62	41.74	13.07	6.53	3.99	0.00	0.00
Neural stem cells, donor2	11352-117H2	11.55	9.63	34.66	0.00	11.55	3.85	0.00	0.00
Neurons, donor1	11494-119E9	12.52	0.00	4.55	0.00	1.14	4.55	0.00	0.00
Neurons, donor2	11574-120E8	42.93	4.84	22.02	5.94	4.62	5.06	0.00	0.00
Neurons, donor3	11655-122E8	2.47	0.82	7.40	0.82	2.47	1.64	0.00	0.00
Neutrophils, donor1	11233-116C9	130.85	5.57	14.85	9.28	2.78	0.00	15.78	0.93
Neutrophils, donor2	11314-117C9	75.37	8.70	11.60	8.70	2.90	0.00	0.00	0.00
Neutrophils, donor3	11390-118C4	36.65	6.11	6.11	4.89	1.22	0.61	8.55	0.00
Nucleus Pulposus Cell, donor1	11252-116F1	26.60	22.80	19.59	5.94	3.09	2.73	0.00	0.00
Nucleus Pulposus Cell, donor2	11409-118E5	26.05	14.33	7.49	3.58	1.63	0.98	0.00	0.65
Nucleus Pulposus Cell, donor3	11462-119B4	14.24	9.83	5.41	1.80	0.60	0.60	0.00	0.00
Olfactory epithelial cells, donor1	11933-125I7	7.57	6.61	2.89	1.38	0.55	0.83	0.00	0.00
Olfactory epithelial cells, donor2	11934-125I8	8.83	6.51	3.18	3.18	0.58	0.43	0.00	0.29
Olfactory epithelial cells, donor3	11935-125I9	9.42	7.26	4.65	1.36	0.79	0.23	0.00	0.00
Olfactory epithelial cells, donor4	11936-126A1	9.74	6.62	6.43	3.31	1.27	0.58	0.00	0.00
Oligodendrocyte - precursors, donor1	11496-119F2	28.89	9.03	7.82	4.21	1.20	0.00	0.00	0.00
Osteoblast - differentiated, donor1	11276-116H7	27.22	13.19	16.16	5.10	4.25	1.49	0.00	0.00
Osteoblast - differentiated, donor2	11353-117H3	21.72	9.14	9.14	4.57	2.29	1.14	0.00	0.00
Osteoblast - differentiated, donor3	11425-118G3	15.52	12.41	8.69	2.48	0.62	1.86	0.00	0.62
Osteoblast, donor1	11277-116H8	18.37	10.75	5.86	3.52	1.17	0.98	0.00	0.20
Osteoblast, donor2	11354-117H4	19.66	16.15	8.43	2.11	1.40	1.40	0.00	0.00
Osteoblast, donor3	11426-118G4	14.04	8.53	6.40	2.67	0.89	0.53	0.00	0.00
Pancreatic stromal cells, donor1	11249-116E7	49.36	22.66	12.97	4.97	2.02	1.68	0.00	0.17
Pericytes, donor1	11491-119E6	49.29	23.03	16.02	5.90	4.67	3.00	0.00	0.11
Pericytes, donor2	11571-120E5	15.85	5.89	11.54	2.04	0.91	2.49	0.00	0.23
Pericytes, donor3	11652-122E5	17.29	6.92	6.92	5.70	1.63	1.83	0.00	0.00
Perineurial Cells, donor1	11499-119F5	20.00	11.98	12.88	2.83	2.94	1.81	0.00	0.11
Perineurial Cells, donor2	11579-120F4	44.81	26.50	9.02	4.32	0.64	0.64	0.00	0.09
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	105.82	16.89	14.02	6.69	3.51	1.59	1.59	0.00
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	84.23	10.53	11.51	3.92	1.22	1.22	1.96	0.00
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	41.54	7.38	8.02	5.18	0.78	0.91	1.81	0.13
Placental Epithelial Cells, donor1	11278-116H9	41.14	7.41	3.35	2.15	2.15	0.72	0.00	0.00
Placental Epithelial Cells, donor2	11355-117H5	73.19	24.40	14.42	3.33	1.11	0.00	0.00	0.00
Placental Epithelial Cells, donor3	11427-118G5	61.45	15.31	10.99	6.68	2.36	2.16	0.00	0.00
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	22.15	6.33	6.96	3.80	0.95	0.63	0.00	0.63
Preadipocyte - breast, donor1	11467-119B9	18.95	12.38	11.44	2.81	1.31	1.50	0.00	0.00
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	19.06	6.66	8.09	2.74	1.04	1.44	0.00	0.00
Preadipocyte - breast, donor2	11328-117E5	17.79	6.75	6.98	3.83	2.03	0.23	0.00	0.00
Preadipocyte - omental, donor1	11468-119C1	46.03	16.62	19.82	9.91	2.66	3.94	0.00	0.00
Preadipocyte - omental, donor2	11329-117E6	26.19	9.17	11.78	3.93	1.75	0.87	0.00	0.00
Preadipocyte - omental, donor3	11403-118D8	23.35	6.88	10.31	3.58	2.01	1.15	0.00	0.00
Preadipocyte - perirenal, donor1	11469-119C2	48.23	12.80	15.75	1.97	3.94	0.00	0.00	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	18.43	10.13	4.30	2.46	1.23	0.61	0.00	0.00
Preadipocyte - subcutaneous, donor2	11356-117H6	26.56	19.48	10.09	6.37	0.89	0.53	0.00	0.00
Preadipocyte - subcutaneous, donor3	11428-118G6	26.22	12.94	9.54	4.43	1.53	1.36	0.17	0.00
Preadipocyte - visceral, donor1	11280-116I2	40.80	23.47	12.57	4.38	1.30	1.30	0.00	0.00
Preadipocyte - visceral, donor2	11357-117H7	45.10	11.96	14.27	6.90	2.30	2.76	0.00	0.46
Preadipocyte - visceral, donor3	11429-118G7	34.59	14.42	8.05	4.39	1.15	1.04	0.00	0.21
Prostate Epithelial Cells (polarized), donor1	11253-116F2	36.51	6.94	9.65	3.17	2.26	0.91	0.00	0.00
Prostate Epithelial Cells, donor2	11331-117E8	249.84	22.34	16.39	16.39	3.11	1.76	0.00	1.08
Prostate Epithelial Cells, donor3	11404-118D9	115.31	9.49	15.62	14.33	7.41	1.96	0.00	0.37
Prostate Stromal Cells, donor1	11254-116F3	18.57	7.63	5.58	2.05	0.91	0.68	0.00	0.11
Prostate Stromal Cells, donor2	11332-117E9	18.11	8.61	9.14	3.05	0.90	0.72	0.00	0.36
Prostate Stromal Cells, donor3	11405-118E1	23.04	10.95	10.95	5.21	2.19	1.67	0.00	0.21
Renal Cortical Epithelial Cells, donor1	11516-119H4	47.45	27.01	10.22	4.38	1.46	0.73	0.00	0.00
Renal Cortical Epithelial Cells, donor2	11596-120H3	50.46	15.18	12.34	7.28	3.12	1.87	0.00	0.07
Renal Epithelial Cells, donor1	11517-119H5	30.94	24.35	5.58	2.03	1.52	0.51	0.00	0.00
Renal Epithelial Cells, donor2	11597-120H4	25.61	10.67	4.27	1.42	0.71	0.00	0.00	0.00
Renal Epithelial Cells, donor3	11678-122H4	28.37	12.70	11.12	3.92	2.22	1.48	0.00	0.00
Renal Glomerular Endothelial Cells, donor1	11514-119H2	25.19	15.66	8.85	1.36	0.68	1.36	0.00	0.68
Renal Glomerular Endothelial Cells, donor2	11594-120H1	40.97	18.73	8.89	2.83	0.67	1.89	0.00	0.13
Renal Glomerular Endothelial Cells, donor3	11675-122H1	24.20	11.10	5.11	4.22	1.55	0.22	0.22	0.00
Renal Glomerular Endothelial Cells, donor4	11783-124B1	21.96	9.32	11.98	2.66	0.67	0.00	0.00	0.00
Renal Mesangial Cells, donor1	11518-119H6	36.75	18.71	9.46	3.30	2.42	1.32	0.00	0.00
Renal Mesangial Cells, donor2	11598-120H5	30.72	18.18	6.27	5.02	0.63	1.25	0.00	0.00
Renal Mesangial Cells, donor3	11679-122H5	28.85	11.37	5.83	3.05	1.39	0.83	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	37.85	18.52	5.91	1.34	1.07	0.54	0.27	0.00
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	32.47	8.43	4.64	3.37	0.42	0.42	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	21.21	10.22	4.63	1.74	1.35	0.58	0.00	0.00
Retinal Pigment Epithelial Cells, donor0	11215-116A9	37.86	14.78	12.19	3.11	3.11	1.04	0.00	0.00
Retinal Pigment Epithelial Cells, donor1	11528-119I7	26.43	17.62	7.96	2.84	1.14	2.56	0.00	0.00
Retinal Pigment Epithelial Cells, donor2	11608-120I6	36.02	12.35	5.15	0.00	0.00	1.03	0.00	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	23.08	10.79	10.29	5.52	4.27	0.75	0.00	0.00
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	234.40	12.96	18.58	15.37	2.41	4.14	0.00	0.40
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	8.93	4.47	10.72	5.36	3.57	1.79	0.00	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	35.77	8.26	30.27	6.05	3.30	5.50	0.00	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	23.20	5.80	16.24	6.96	3.48	4.06	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	16.38	5.46	8.84	1.43	1.56	1.56	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	13.60	3.08	6.85	1.49	1.19	1.29	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	20.75	4.91	11.27	3.01	1.78	1.23	0.00	0.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	15.26	3.85	7.07	1.74	1.49	0.87	0.00	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	13.52	3.73	7.23	3.61	0.93	1.17	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	17.33	4.39	7.86	3.93	1.39	1.62	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	13.83	1.64	6.43	0.82	0.96	1.51	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	8.93	4.24	6.50	1.82	0.30	0.76	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	18.46	5.20	6.09	1.79	1.25	1.61	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	14.49	3.73	7.03	1.43	1.43	1.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	14.59	3.54	7.40	2.04	1.93	1.07	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	14.83	6.20	5.97	1.11	1.99	1.77	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	12.62	2.29	6.69	0.96	0.76	0.57	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	14.07	2.52	4.66	1.30	1.77	1.21	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	20.48	6.01	12.59	4.32	2.63	0.94	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	14.73	2.12	3.85	1.46	1.06	1.19	0.00	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	11.58	3.21	8.37	2.04	1.07	0.68	0.00	0.10
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	17.95	5.54	8.98	2.48	0.95	3.06	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	12.82	4.16	5.87	2.24	0.96	1.17	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	10.65	2.80	8.41	1.68	1.12	1.40	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	14.70	3.59	6.15	2.56	1.54	1.20	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	13.49	1.46	5.47	1.46	1.28	1.64	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	12.02	3.68	8.58	0.86	1.35	0.86	0.00	0.37
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	17.46	2.28	6.98	2.55	1.61	1.48	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	14.62	2.36	8.49	1.18	0.94	1.18	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	13.49	3.57	6.94	2.78	1.98	1.98	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	13.56	2.81	7.48	2.34	1.87	1.17	0.00	0.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	13.69	2.28	9.33	1.24	0.83	1.87	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	9.95	3.10	4.87	2.43	0.88	0.44	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	15.46	5.22	7.10	1.67	1.46	0.84	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	10.23	3.36	5.92	1.62	1.35	1.48	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	13.11	3.58	4.60	2.38	1.02	1.19	0.00	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	14.65	2.51	6.94	2.31	1.35	1.16	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	18.57	1.89	6.02	1.20	0.52	1.20	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	12.89	2.88	5.49	0.96	0.82	1.10	0.00	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	16.25	5.58	7.72	2.96	1.48	0.82	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	17.04	5.62	9.71	1.02	0.85	2.39	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	16.57	4.59	8.29	2.07	1.78	1.63	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	15.46	3.73	7.73	2.93	1.60	1.33	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	19.08	2.63	10.23	1.80	1.52	1.66	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	25.00	8.81	11.67	1.67	1.90	3.33	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	26.20	6.45	13.50	3.63	1.01	2.42	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	26.37	5.56	8.48	1.60	1.70	1.79	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	21.66	3.84	13.97	3.14	1.75	2.45	0.00	0.35
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	21.76	3.02	11.48	4.53	2.12	2.42	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	26.31	5.26	10.65	2.45	1.71	2.57	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	22.71	3.49	11.64	2.62	4.08	2.77	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	20.08	2.43	12.17	3.04	1.83	3.04	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	27.73	4.52	10.85	2.71	1.81	1.51	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	25.56	4.98	15.15	5.88	3.17	3.62	0.23	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	21.27	5.99	17.37	5.09	6.59	2.40	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	34.12	6.02	17.83	3.66	4.49	3.54	0.00	0.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	22.20	4.70	13.45	3.84	2.13	3.63	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	16.23	1.80	10.82	4.81	1.20	1.80	0.00	0.00
Schwann Cells, donor1	11498-119F4	20.88	15.61	6.77	2.07	0.56	0.75	0.00	0.38
Schwann Cells, donor2	11578-120F3	6.80	17.01	3.40	6.80	3.40	0.00	0.00	0.00
Schwann Cells, donor3	11659-122F3	30.89	14.90	8.98	5.04	1.10	2.19	0.00	0.22
Sebocyte, donor1	11220-116B5	547.77	44.92	25.75	25.20	4.93	2.19	0.00	0.00
Sebocyte, donor2	11301-117B5	321.23	26.19	10.57	26.65	5.51	0.92	0.00	0.00
Sebocyte, donor3	11378-118B1	126.35	20.61	9.69	11.54	5.36	1.44	0.00	0.62
Sertoli Cells, donor1	11255-116F4	28.16	4.97	16.57	8.28	3.31	0.00	0.00	0.00
Sertoli Cells, donor2	11333-117F1	19.77	2.82	2.82	5.65	5.65	2.82	0.00	0.00
Skeletal Muscle Cells, donor1	11281-116I3	8.53	6.33	8.97	1.06	1.67	1.14	0.00	0.00
Skeletal Muscle Cells, donor2	11358-117H8	5.78	8.67	4.34	0.72	0.00	0.72	0.00	0.00
Skeletal Muscle Cells, donor3	11430-118G8	7.52	8.36	0.84	0.84	0.84	1.67	0.00	0.00
Skeletal Muscle Cells, donor4	11451-119A2	19.64	10.53	3.46	2.36	0.47	0.16	0.00	0.16
Skeletal Muscle Cells, donor5	11455-119A6	23.78	10.55	5.05	1.64	0.59	0.74	0.00	0.45
Skeletal Muscle Cells, donor6	11459-119B1	14.62	6.00	3.69	2.31	0.46	0.46	0.00	0.15
Skeletal Muscle Satellite Cells, donor1	11240-116D7	67.16	43.72	13.86	8.57	1.64	0.88	0.00	0.13
Skeletal Muscle Satellite Cells, donor2	11321-117D7	35.39	20.98	7.42	5.42	1.71	0.86	0.00	0.00
Skeletal Muscle Satellite Cells, donor3	11397-118D2	45.24	10.12	4.07	2.78	1.29	0.50	0.00	0.40
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	11.80	7.16	9.94	1.43	2.19	2.19	0.00	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	7.24	1.45	4.34	0.00	1.45	0.00	0.00	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	14.04	6.33	4.68	1.51	0.14	1.38	0.00	0.00
Skin - palm, donor1	10286-104F7	59.09	13.43	5.37	2.69	0.00	0.00	0.00	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	179.33	17.73	9.66	9.51	2.02	1.30	0.00	0.00
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	211.83	17.99	13.90	14.72	0.82	4.09	0.00	0.82
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	146.32	22.46	5.84	8.18	1.56	1.04	0.00	0.39
Small Airway Epithelial Cells, donor1	11256-116F5	206.84	26.55	18.07	19.60	4.45	1.81	0.00	0.00
Small Airway Epithelial Cells, donor2	11334-117F2	102.68	9.99	5.20	10.41	1.55	0.70	0.00	0.14
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	226.25	27.07	17.97	10.15	4.44	2.33	0.00	0.21
Small Airway Epithelial Cells, donor3	11406-118E2	121.12	16.04	10.04	13.12	3.90	1.27	0.00	0.07
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	9.26	2.78	2.47	1.54	0.31	0.62	0.00	0.00
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	88.49	10.89	33.57	17.34	4.89	4.89	0.00	0.00
Smooth Muscle Cells - Aortic, donor0	11210-116A4	19.99	9.41	4.11	3.53	0.59	0.59	0.00	0.00
Smooth Muscle Cells - Aortic, donor1	11283-116I5	18.12	6.41	7.96	2.21	0.22	0.44	0.00	0.00
Smooth Muscle Cells - Aortic, donor2	11360-117I1	27.56	9.06	7.09	3.15	2.36	1.58	0.00	0.39
Smooth Muscle Cells - Aortic, donor3	11432-118H1	23.18	11.59	6.95	6.18	0.77	0.00	0.00	0.00
Smooth Muscle Cells - Bladder, donor1	11519-119H7	13.01	16.01	11.01	4.00	1.00	0.00	0.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	18.76	5.72	5.06	3.59	0.80	0.53	0.00	0.13
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	15.52	9.53	5.98	2.22	1.99	1.33	0.00	0.22
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	8.32	5.63	3.07	1.41	0.64	0.64	0.00	0.00
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	43.30	20.19	10.42	4.88	0.65	0.33	0.00	0.00
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	32.78	14.77	11.52	5.02	1.77	1.77	0.00	0.00
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	50.97	12.81	7.40	5.69	1.42	1.28	0.00	0.00
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	56.77	19.85	7.65	3.58	1.79	0.98	0.00	0.00
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	27.70	14.92	7.00	8.83	2.13	1.22	0.00	0.00
Smooth Muscle Cells - Carotid, donor1	11285-116I7	19.45	15.41	12.12	3.79	1.01	1.26	0.00	0.00
Smooth Muscle Cells - Carotid, donor2	11362-117I3	12.24	0.00	12.24	0.00	0.00	6.12	0.00	6.12
Smooth Muscle Cells - Carotid, donor3	11434-118H3	7.15	5.25	3.81	3.81	0.00	0.48	0.00	0.48
Smooth Muscle Cells - Colonic, donor1	11239-116D6	56.04	12.24	13.86	7.08	0.88	1.77	0.00	0.00
Smooth Muscle Cells - Colonic, donor2	11320-117D6	44.55	13.34	10.98	6.03	0.65	0.86	0.00	0.43
Smooth Muscle Cells - Colonic, donor3	11396-118D1	35.48	12.80	6.19	4.51	0.73	0.94	0.00	0.00
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	28.46	10.98	8.97	4.49	0.93	1.70	0.00	0.00
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	14.01	12.93	1.08	5.39	0.00	2.16	0.00	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	24.21	11.95	8.07	2.39	0.30	0.90	0.00	0.30
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	44.38	17.41	6.15	2.73	1.02	0.68	0.00	0.00
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	59.13	28.19	9.89	9.27	2.28	0.79	0.00	0.31
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	28.28	9.46	16.61	5.84	1.91	2.52	0.00	0.20
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	24.58	5.01	8.19	3.64	1.14	1.59	0.23	0.23
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	22.94	3.02	4.83	3.02	0.00	0.00	0.00	0.60
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	29.41	10.60	10.33	2.12	1.59	1.06	0.00	0.00
Smooth Muscle Cells - Prostate, donor1	11257-116F6	17.04	7.06	6.39	1.33	1.46	0.93	0.00	0.00
Smooth Muscle Cells - Prostate, donor2	11335-117F3	20.54	9.27	11.39	3.01	1.50	1.25	0.00	0.13
Smooth Muscle Cells - Prostate, donor3	11465-119B7	37.03	18.01	15.73	4.82	2.79	0.76	0.00	0.25
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	30.91	16.74	11.01	4.52	1.96	0.75	0.00	0.30
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	12.00	9.00	8.25	3.00	1.50	2.25	0.00	0.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	7.75	5.17	5.17	3.88	1.29	0.00	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	23.72	10.23	7.44	2.33	0.93	0.47	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	20.70	4.04	10.10	5.55	0.50	2.52	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	17.55	2.51	6.89	3.13	0.63	1.57	0.00	0.31
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	79.35	26.25	9.44	4.13	1.77	0.00	0.00	0.29
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	21.49	12.91	5.25	2.25	0.92	0.67	0.00	0.00
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	40.64	29.43	6.54	6.07	1.40	0.93	0.00	0.00
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	13.38	3.45	3.60	1.87	0.58	0.29	0.00	0.00
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	83.88	5.35	4.59	2.29	0.76	0.00	0.00	0.25
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	7.52	3.01	2.44	1.32	0.56	0.56	0.00	0.19
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	36.47	15.65	10.62	4.47	2.10	1.26	0.00	0.00
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	24.89	9.64	12.32	3.27	3.52	1.51	0.00	0.00
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	24.29	8.57	8.10	6.19	0.48	0.00	0.00	0.48
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	16.64	3.18	4.16	2.94	0.24	0.49	0.00	0.00
Smooth Muscle Cells - Uterine, donor1	11258-116F7	31.60	11.49	11.71	3.31	1.33	1.77	0.00	0.22
Smooth Muscle Cells - Uterine, donor3	11466-119B8	15.80	10.24	6.14	2.93	1.46	0.59	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	26.04	5.83	11.47	7.00	1.75	1.94	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	36.76	10.84	9.26	5.55	0.79	0.26	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	49.10	15.25	19.34	8.55	2.98	3.35	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	63.60	13.30	10.78	8.98	1.08	1.44	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	40.60	10.50	9.65	4.83	0.28	1.14	0.00	0.28
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	26.39	11.82	3.94	1.97	0.00	0.79	0.00	0.00
Smooth muscle cells - airway, control, donor1	11966-126D4	33.52	11.43	11.68	5.08	1.27	2.03	0.00	0.25
Smooth muscle cells - airway, control, donor2	11967-126D5	30.35	9.58	12.78	9.18	3.19	0.80	0.00	0.00
Smooth muscle cells - airway, control, donor3	11968-126D6	42.22	12.12	15.05	7.94	0.42	2.09	0.00	0.00
Smooth muscle cells - airway, control, donor4	11969-126D7	30.71	21.08	13.75	4.58	0.46	2.75	0.00	0.46
Synoviocyte, donor1	11291-117A4	8.92	3.87	7.07	2.86	2.02	1.18	0.00	0.00
Synoviocyte, donor2	11368-117I9	25.14	12.24	10.56	5.03	2.68	1.84	0.00	0.17
Synoviocyte, donor3	11440-118H9	12.96	11.62	10.28	3.13	0.67	1.56	0.00	0.22
Trabecular Meshwork Cells, donor1	11532-120A2	43.59	25.73	10.01	2.50	2.50	1.07	0.00	0.00
Trabecular Meshwork Cells, donor2	11612-122A1	19.82	1.98	5.95	1.98	0.00	0.00	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	19.91	11.58	5.56	3.47	1.85	0.69	0.00	0.00
Tracheal Epithelial Cells, donor1	11292-117A5	225.38	30.32	13.05	11.61	3.23	1.58	0.00	0.00
Tracheal Epithelial Cells, donor2	11369-118A1	156.17	14.30	5.03	8.50	1.55	0.77	0.00	0.00
Tracheal Epithelial Cells, donor3	11441-118I1	144.31	12.60	5.15	6.87	0.57	0.00	0.00	0.00
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	250.23	14.15	21.78	15.50	3.94	1.11	0.25	0.25
Urethra, donor2	10319-105A4	52.15	1.80	8.99	12.59	1.80	0.00	1.80	0.00
Urothelial Cells, donor1	11520-119H8	344.30	44.37	15.94	15.41	2.66	3.98	0.00	0.27
Urothelial Cells, donor2	11600-120H7	250.35	28.04	13.22	20.83	2.40	1.60	0.00	0.00
Urothelial Cells, donor3	11681-122H7	241.12	29.11	13.75	18.79	5.50	2.06	0.00	0.46
Urothelial cells, donor0	11216-116B1	205.96	45.69	15.16	13.82	4.01	1.56	0.00	0.00
Whole blood (ribopure), donor090309, donation1	12179-129A1	71.18	8.01	7.12	5.34	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090309, donation2	12180-129A2	64.33	5.72	8.58	0.00	0.00	1.43	2.86	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	27.38	8.21	6.85	3.42	0.00	2.05	0.68	0.00
Whole blood (ribopure), donor090325, donation1	12176-128I7	47.86	11.71	8.61	2.41	2.41	0.34	2.41	0.00
Whole blood (ribopure), donor090325, donation2	12177-128I8	46.48	8.13	5.81	0.58	1.74	0.00	2.32	0.00
Whole blood (ribopure), donor090612, donation1	12182-129A4	60.39	6.25	6.25	5.21	1.04	1.04	1.04	0.00
Whole blood (ribopure), donor090612, donation2	12183-129A5	67.00	11.93	7.34	1.84	3.67	0.92	0.00	0.92
Whole blood (ribopure), donor090612, donation3	12184-129A6	30.13	3.65	8.22	1.83	0.91	0.91	2.74	0.00
Wilms' tumor cell line:G-401	10809-111A8	38.24	13.82	3.70	3.58	0.74	0.12	0.00	0.12
Wilms' tumor cell line:HFWT	10597-108E3	4.40	1.76	8.80	1.76	1.76	0.88	0.00	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	87.99	37.43	12.85	5.03	2.79	1.68	0.00	0.28
achilles tendon, donor2	10292-104G4	57.86	10.33	2.07	2.07	0.00	0.00	0.00	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	290.90	13.77	9.18	5.35	4.59	2.04	10.71	0.00
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	38.08	14.16	2.55	0.93	1.39	0.00	1.86	0.00
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	10.21	4.15	1.19	0.71	1.78	0.47	74.79	0.12
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	8.44	4.63	3.81	0.27	2.45	1.63	22.31	0.00
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	19.68	7.87	3.94	3.09	0.56	0.56	0.28	0.56
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	40.82	7.19	3.60	1.90	0.42	0.85	2.54	0.00
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	28.04	3.54	2.18	1.36	0.54	0.00	1.09	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	72.71	13.22	13.22	9.25	1.32	0.44	0.00	0.44
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	153.13	22.46	33.49	12.25	6.94	6.13	0.00	0.00
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	46.21	11.65	10.10	2.72	0.78	0.00	0.39	0.00
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	37.72	9.75	5.34	5.89	2.39	0.55	4.23	0.00
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	105.31	19.50	0.00	11.70	0.00	0.00	19.50	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	17.89	10.22	7.20	3.49	0.46	1.16	0.93	0.00
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	30.55	12.69	9.58	6.73	1.04	1.29	0.00	0.26
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	78.32	19.00	11.69	5.84	0.88	1.46	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	77.15	7.44	4.18	6.51	1.39	0.93	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	80.61	12.34	16.45	11.93	0.00	1.65	0.00	0.41
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	51.57	11.66	6.14	3.38	0.61	0.92	0.00	0.31
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	80.65	11.95	14.08	5.12	0.43	0.43	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	99.78	25.78	12.44	3.94	1.52	0.61	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	105.19	21.42	14.20	5.05	1.93	0.48	0.00	0.24
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	188.66	19.16	6.90	11.58	2.00	0.89	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	41.36	6.34	6.00	4.67	1.33	0.67	7.67	0.00
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	74.33	16.72	3.72	5.57	0.00	3.72	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	22.22	8.66	7.53	1.51	1.13	1.88	4.14	0.00
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	26.17	9.16	11.34	5.23	1.31	0.00	1.74	0.00
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	33.74	9.37	5.62	3.75	0.00	0.00	0.00	0.00
adenocarcinoma cell line:IM95m	10796-110I4	20.96	10.36	1.88	1.88	0.24	0.24	0.00	0.47
adipose tissue, adult, pool1	10010-101C1	297.83	18.46	24.20	15.51	4.50	2.64	0.31	0.62
adipose, donor1	10184-103D4	24.04	9.38	2.35	1.17	1.17	0.00	0.00	0.59
adipose, donor2	10185-103D5	8.92	3.65	5.68	0.81	2.03	1.22	0.00	0.00
adipose, donor3	10186-103D6	15.79	5.45	3.54	1.91	1.91	0.27	0.00	0.27
adipose, donor4	10187-103D7	19.94	9.53	0.87	0.87	3.47	0.00	0.00	0.00
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	35.35	2.37	20.99	6.63	4.73	5.05	0.00	0.00
adrenal gland, adult, pool1	10081-102A9	32.74	14.55	7.28	14.55	0.00	3.64	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	51.23	13.34	8.80	4.00	2.27	1.20	2.13	0.13
alveolar cell carcinoma cell line:SW 1573	10708-109H6	12.51	7.50	10.00	1.07	1.43	0.36	0.00	0.00
amniotic membrane cells, donor1	12235-129G3	166.70	19.24	20.40	17.16	1.85	0.93	0.00	0.46
amniotic membrane cells, donor2	12236-129G4	156.54	6.76	18.26	11.50	5.41	3.04	0.00	0.00
amniotic membrane cells, donor3	12237-129G5	144.35	17.68	25.63	22.10	2.95	2.06	0.00	0.00
amygdala - adult, donor10196	10167-103B5	16.60	5.93	27.27	5.93	7.11	3.56	0.00	0.00
amygdala, adult, donor10252	10151-102I7	32.04	5.68	32.04	17.64	5.88	5.68	0.00	0.00
amygdala, newborn, donor10223	10360-105E9	17.75	1.94	11.94	2.26	0.97	1.61	0.00	0.00
anaplastic carcinoma cell line:8305C	10428-106D5	25.34	5.09	10.06	1.78	1.66	1.66	0.00	0.00
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	33.76	7.50	9.93	3.97	1.32	1.76	0.00	0.00
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	36.08	9.35	13.03	3.01	0.67	1.67	0.00	0.00
aorta, adult, pool1	10052-101G7	27.46	7.65	19.42	6.67	1.37	1.57	0.20	0.39
appendix, adult	10189-103D9	114.49	8.93	10.87	9.31	1.16	1.16	2.72	0.00
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	38.18	15.48	11.35	7.22	3.44	2.06	0.00	0.00
artery, adult	10190-103E1	16.30	4.08	4.08	2.72	0.00	1.36	0.00	0.00
astrocytoma cell line:TM-31	10425-106D2	19.70	2.17	6.81	1.74	1.45	0.87	0.00	0.00
b cell line:RPMI1788	10427-106D4	533.24	25.28	12.04	10.86	3.27	1.78	5.20	0.30
basal cell carcinoma cell line:TE 354.T	10702-109G9	20.81	7.49	6.94	4.99	0.83	0.83	0.00	0.00
bile duct carcinoma cell line:HuCCT1	10432-106D9	26.49	7.94	3.47	3.18	0.40	0.60	0.00	0.00
bile duct carcinoma cell line:TFK-1	10496-107C1	2.51	0.00	0.50	0.17	0.00	0.00	0.00	0.00
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	33.55	13.42	7.83	4.47	1.68	1.12	0.00	0.00
bladder, adult, pool1	10011-101C2	40.52	15.32	20.75	8.91	2.93	2.82	0.00	0.00
blood, adult, pool1	10053-101G8	22.15	11.07	4.43	4.43	2.21	0.00	0.00	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	25.69	5.99	6.85	1.71	0.00	0.00	0.00	0.00
bone marrow, adult	10192-103E3	107.97	14.85	29.69	19.57	0.67	2.70	0.00	0.00
brain, adult, donor1	10084-102B3	26.65	2.05	28.70	9.23	6.15	2.05	0.00	1.03
brain, adult, pool1	10012-101C3	36.53	6.12	52.45	15.81	8.80	6.90	0.00	0.11
brain, fetal, pool1	10085-102B4	0.00	0.00	5.34	2.67	0.00	0.00	0.00	0.00
breast carcinoma cell line:MCF7	10482-107A5	14.87	5.95	11.23	4.29	1.32	0.66	0.00	0.00
breast carcinoma cell line:MDA-MB-453	10419-106C5	51.80	10.86	14.35	5.62	1.75	0.75	0.00	0.00
breast, adult, donor1	10080-102A8	22.73	3.79	3.79	4.42	0.00	0.00	0.63	0.00
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	73.30	15.75	7.75	2.79	1.91	0.64	0.00	0.38
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	17.63	3.40	5.88	1.55	0.93	0.31	0.00	0.00
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	104.98	27.17	24.40	18.42	5.30	2.76	1.15	0.69
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	79.40	8.96	14.53	5.08	1.21	1.94	0.00	0.00
carcinoid cell line:NCI-H1770	10703-109H1	10.34	1.88	4.70	1.88	3.29	0.94	0.00	0.00
carcinoid cell line:NCI-H727	10735-110B6	11.48	3.94	4.70	1.31	0.44	0.33	0.00	0.00
carcinoid cell line:SK-PN-DW	10719-109I8	6.65	3.80	3.49	0.63	4.75	0.95	0.00	0.32
carcinosarcoma cell line:JHUCS-1	10642-109A3	18.37	8.78	9.32	3.99	0.80	1.33	0.00	0.27
caudate nucleus - adult, donor10196	10177-103C6	17.27	1.15	32.24	20.72	3.45	5.76	0.00	0.00
caudate nucleus, adult, donor10252	10164-103B2	21.92	4.02	21.42	13.72	9.20	3.01	0.00	0.33
caudate nucleus, adult, donor10258	10379-105H1	24.45	8.41	19.10	7.64	8.41	4.58	0.00	0.00
caudate nucleus, newborn, donor10223	10354-105E3	15.02	0.73	14.28	4.76	2.20	3.66	0.00	0.00
cerebellum - adult, donor10196	10173-103C2	20.39	2.91	32.05	14.57	8.74	0.00	0.00	0.00
cerebellum, adult, donor10252	10166-103B4	21.56	6.41	24.13	14.31	5.34	3.20	0.00	0.00
cerebellum, adult, pool1	10083-102B2	22.08	4.14	21.39	6.55	3.10	2.41	0.00	0.69
cerebellum, newborn, donor10223	10357-105E6	20.76	0.83	19.93	5.81	2.49	2.49	0.00	0.00
cerebral meninges, adult	10188-103D8	20.42	5.04	22.44	7.06	3.03	0.76	0.00	0.00
cerebrospinal fluid, donor2	10294-104G6	22.66	4.39	7.31	3.65	0.73	0.73	0.00	0.00
cervical cancer cell line:D98-AH2	10552-107I3	12.94	9.78	9.78	4.60	1.44	0.86	0.00	0.00
cervical cancer cell line:ME-180	10553-107I4	510.24	26.35	36.79	35.13	8.45	8.62	0.00	0.50
cervix, adult, pool1	10013-101C4	91.76	17.43	31.92	13.75	4.30	2.41	0.31	0.21
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	48.21	5.02	14.63	6.41	0.98	0.98	0.00	0.00
chondrosarcoma cell line:SW 1353	10700-109G7	6.53	3.92	3.92	3.92	0.00	0.00	0.00	0.00
choriocarcinoma cell line:BeWo	10423-106C9	908.71	29.70	14.54	16.53	6.21	3.11	0.00	1.12
choriocarcinoma cell line:SCH	10785-110H2	235.95	3.70	8.38	5.91	1.85	0.99	0.00	0.00
choriocarcinoma cell line:T3M-3	10618-108G6	262.79	11.86	1.66	4.03	1.19	0.47	0.00	0.24
chorionic membrane cells, donor1	12238-129G6	280.36	12.82	16.24	10.54	3.13	1.71	0.28	0.57
chorionic membrane cells, donor2	12239-129G7	267.57	11.14	17.60	12.33	6.46	2.88	0.10	0.30
chorionic membrane cells, donor3	12240-129G8	543.99	18.13	28.02	26.38	5.49	7.69	0.00	0.55
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	4.04	6.06	3.03	2.02	1.01	0.00	36.35	0.00
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	15.37	6.72	2.69	1.92	0.96	0.77	0.77	0.00
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	59.34	13.09	4.86	4.01	1.27	1.90	1.69	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	6.42	4.88	3.34	1.03	0.26	0.00	0.26	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	6.05	5.32	3.14	0.24	0.48	0.48	0.00	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	4.28	4.68	2.85	1.22	0.81	0.41	0.00	0.00
chronic myelogenous leukemia cell line:K562	10454-106G4	21.20	16.20	4.71	2.06	2.06	0.88	0.00	0.00
chronic myelogenous leukemia cell line:KU812	10409-106B4	37.53	14.33	3.13	0.78	1.04	0.26	0.00	0.00
clear cell carcinoma cell line:JHOC-5	10638-108I8	37.26	6.17	8.23	6.63	1.60	1.37	0.00	0.46
clear cell carcinoma cell line:TEN	10636-108I6	32.10	5.73	6.77	6.07	0.35	0.52	0.00	0.00
colon carcinoma cell line:CACO-2	10513-107D9	83.47	21.23	8.05	3.11	1.46	1.28	0.00	0.00
colon carcinoma cell line:COLO-320	10420-106C6	31.55	16.72	4.56	2.66	2.66	1.90	0.00	0.00
colon, adult, donor1	10082-102B1	20.23	16.66	9.52	2.38	1.19	0.00	2.38	0.00
colon, adult, pool1	10014-101C5	37.95	10.81	8.81	4.58	1.29	0.82	0.12	0.12
colon, fetal, donor1	10070-101I7	24.10	8.03	4.33	8.03	1.85	0.00	0.00	0.00
common myeloid progenitor CMP, donor1	12130-128D6	9.17	13.75	18.33	0.00	0.00	0.00	0.00	0.00
common myeloid progenitor CMP, donor2	12134-128E1	25.04	0.00	0.00	0.00	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	29.75	2.97	3.82	0.85	0.00	0.85	0.00	0.00
cord blood derived cell line:COBL-a 24h infection	10453-106G3	52.68	8.75	3.47	2.57	0.45	0.45	0.00	0.00
cord blood derived cell line:COBL-a untreated	10449-106F8	59.51	9.87	4.65	3.10	0.71	0.85	0.00	0.00
corpus callosum, adult, pool1	10042-101F6	102.05	12.60	132.01	36.82	19.57	16.36	0.00	0.11
cruciate ligament, donor2	10295-104G7	28.37	5.67	7.29	2.43	0.81	0.81	0.00	0.81
diaphragm, fetal, donor1	10069-101I6	41.73	6.42	7.22	4.82	1.61	0.80	0.00	0.00
diencephalon, adult	10193-103E4	38.88	6.48	34.80	19.68	7.92	5.76	0.00	0.48
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	21.58	3.21	0.92	1.61	0.23	0.23	0.23	0.23
ductal cell carcinoma cell line:KLM-1	10438-106E6	65.14	8.46	13.08	3.85	2.31	1.80	0.00	0.00
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	41.40	8.67	7.22	4.57	0.24	0.96	0.00	0.00
ductus deferens, adult	10196-103E7	29.40	7.97	7.48	4.49	2.99	1.00	0.00	0.00
duodenum, fetal, donor1, tech_rep1	10071-101I8	18.72	8.64	8.64	5.76	2.88	0.00	0.00	0.00
duodenum, fetal, donor1, tech_rep2	10071-101I8	38.99	8.09	19.13	7.36	0.74	0.00	5.15	0.00
dura mater, adult, donor1	10041-101F5	96.21	24.94	34.19	12.80	3.88	4.13	0.00	0.00
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	8.66	2.66	2.00	0.22	0.22	0.22	0.00	0.00
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	35.82	15.62	7.16	2.72	1.58	1.29	0.00	0.00
embryonic pancreas cell line:1B2C6	10604-108F1	4.93	0.62	1.23	1.23	1.23	1.23	0.00	0.00
embryonic pancreas cell line:1C3D3	10605-108F2	6.05	2.42	5.45	3.33	2.42	1.21	0.00	0.00
embryonic pancreas cell line:1C3IKEI	10606-108F3	6.48	1.85	2.47	0.00	0.31	0.00	0.00	0.00
embryonic pancreas cell line:2C6	10603-108E9	5.25	0.00	2.63	1.31	0.00	1.31	0.00	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	18.77	2.01	3.02	0.67	0.00	0.00	0.00	0.00
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	12.14	3.44	14.68	2.90	5.62	2.54	0.00	0.00
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	39.72	7.40	6.75	5.15	0.64	1.45	0.00	0.32
epidermoid carcinoma cell line:A431	10426-106D3	173.96	18.79	6.89	8.34	1.11	1.00	0.33	0.11
epidermoid carcinoma cell line:Ca Ski	10431-106D8	26.51	10.23	5.28	1.87	1.21	0.55	0.00	0.00
epididymis, adult	10197-103E8	51.49	9.84	19.47	11.51	3.98	2.93	0.21	0.42
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	31.40	15.43	6.92	4.26	1.42	0.35	0.00	0.00
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	25.56	3.54	2.75	0.39	0.39	0.79	0.00	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	11.93	3.67	2.75	2.10	0.39	0.39	0.00	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	11.61	4.63	2.95	1.48	0.10	0.39	0.00	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	14.00	6.27	2.46	2.24	1.12	0.11	0.00	0.00
esophagus, adult, pool1	10015-101C6	144.08	33.55	20.28	14.55	4.03	1.91	0.00	0.21
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	49.09	17.41	23.04	10.52	5.01	2.88	0.00	0.00
eye - muscle inferior rectus, donor1	10272-104E2	12.07	2.41	9.66	4.83	0.00	0.00	0.00	0.00
eye - muscle lateral, donor2	10298-104H1	14.73	2.10	4.21	6.31	0.00	0.00	0.00	0.00
eye - muscle medial, donor2	10299-104H2	7.44	0.00	1.49	1.49	0.00	1.49	0.00	0.00
eye - muscle superior, donor2	10297-104G9	22.93	1.15	4.59	4.59	1.15	0.00	0.00	1.15
eye - vitreous humor, donor1	10268-104D7	30.61	7.29	2.91	4.37	1.46	2.91	0.00	0.00
eye, fetal, donor1	10054-101G9	23.90	10.68	17.54	10.17	5.34	2.03	0.25	0.00
fibrosarcoma cell line:HT-1080	10758-110E2	8.08	2.82	3.72	1.54	0.38	0.77	0.51	0.00
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	23.27	7.83	4.04	3.32	0.47	0.24	0.71	0.00
frontal lobe, adult, pool1	10040-101F4	35.47	6.85	45.60	11.82	7.41	5.63	0.00	0.00
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	33.63	10.81	8.11	2.40	0.90	0.60	0.00	0.00
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	48.74	8.32	43.07	13.53	5.03	4.21	0.09	0.00
gall bladder, adult	10198-103E9	30.90	7.48	18.11	8.93	1.21	2.66	0.24	0.24
gamma delta positive T cells, donor1	11937-126A2	14.50	9.66	5.37	1.61	2.15	2.15	0.00	0.00
gamma delta positive T cells, donor2	11938-126A3	17.55	7.84	5.98	2.24	0.37	1.49	0.37	0.00
gastric adenocarcinoma cell line:MKN1	10614-108G2	20.91	8.03	7.60	4.22	0.21	0.42	0.00	0.21
gastric adenocarcinoma cell line:MKN45	10612-108F9	17.99	6.96	6.77	3.29	0.97	1.35	0.00	0.00
gastric cancer cell line:AZ521	10549-107H9	43.61	5.08	13.94	3.28	2.30	1.31	0.00	0.00
gastric cancer cell line:GSS	10560-108A2	30.20	10.07	10.07	2.75	3.66	2.75	0.92	0.00
gastrointestinal carcinoma cell line:ECC12	10615-108G3	1.14	0.00	0.91	0.23	0.46	0.00	0.00	0.00
giant cell carcinoma cell line:LU65	10487-107B1	1.38	1.03	1.38	0.11	0.34	0.00	0.00	0.00
giant cell carcinoma cell line:Lu99B	10433-106E1	28.55	12.60	3.22	3.64	0.98	0.84	0.00	0.00
glassy cell carcinoma cell line:HOKUG	10688-109F4	83.56	6.48	13.97	9.73	1.50	1.00	0.00	0.25
glioblastoma cell line:A172, tech_rep1	10444-106F3	16.57	6.33	8.66	2.11	0.95	1.37	0.00	0.00
glioblastoma cell line:A172, tech_rep2	10444-106F3	12.36	7.30	8.57	3.09	1.54	0.84	0.00	0.00
glioblastoma cell line:T98G	10485-107A8	50.88	20.75	13.24	6.40	3.53	2.10	0.00	0.00
glioma cell line:GI-1	10413-106B8	31.05	12.01	9.96	4.39	2.05	0.88	0.00	0.00
globus pallidus - adult, donor10196	10175-103C4	34.99	2.92	52.48	13.12	5.10	5.10	0.00	0.00
globus pallidus, adult, donor10252	10161-103A8	66.15	8.54	48.57	36.13	11.72	4.39	0.00	0.00
globus pallidus, adult, donor10258	10367-105F7	36.97	4.11	42.45	10.95	2.74	0.00	0.00	0.00
globus pallidus, newborn, donor10223	10364-105F4	21.85	4.26	26.65	7.99	5.86	5.33	0.00	0.00
granulocyte macrophage progenitor, donor1	12131-128D7	68.52	7.34	4.89	2.45	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	98.36	0.00	0.00	0.00	10.93	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	73.17	10.45	10.45	5.23	0.00	10.45	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	12.48	4.48	4.16	4.16	0.64	0.96	0.00	0.00
hIPS +CCl2, biol_rep1	14383-156B9	61.06	18.36	5.05	5.05	4.59	0.46	0.00	0.00
hIPS +CCl2, biol_rep2	14384-156C1	69.50	17.38	5.94	5.49	0.91	0.00	0.00	0.00
hIPS +CCl2, biol_rep3	14385-156C2	59.26	24.48	5.80	1.29	0.64	0.00	0.00	0.00
hIPS, biol_rep1	14380-156B6	37.37	4.31	7.19	2.87	0.00	0.00	0.00	0.00
hIPS, biol_rep2	14381-156B7	34.29	10.29	2.06	2.06	0.00	0.00	0.00	0.00
hIPS, biol_rep3	14382-156B8	46.35	5.52	30.90	9.93	2.21	2.21	0.00	0.00
hairy cell leukemia cell line:Mo	10712-109I1	152.29	8.05	4.88	6.32	0.86	0.86	0.00	0.29
heart - mitral valve, adult	10205-103F7	29.90	4.48	17.04	4.19	3.29	2.39	0.30	0.30
heart - pulmonic valve, adult	10206-103F8	37.65	6.28	9.94	7.32	2.35	1.31	0.26	0.26
heart - tricuspid valve, adult	10207-103F9	2.50	0.83	4.16	1.67	0.00	0.83	0.83	0.00
heart, adult, diseased post-infarction, donor1	10050-101G5	53.26	6.33	12.65	8.77	4.90	1.84	0.00	0.20
heart, adult, diseased, donor1	10051-101G6	38.75	7.66	7.24	7.66	0.85	1.28	0.00	0.00
heart, adult, pool1	10016-101C7	40.94	6.67	8.05	4.60	0.23	0.92	0.00	0.00
heart, fetal, pool1	10046-101G1	142.11	21.05	26.59	11.40	4.62	2.98	0.21	0.10
hepatic mesenchymal tumor cell line:LI90	10778-110G4	9.26	4.32	11.72	4.32	3.09	0.93	0.00	0.00
hepatoblastoma cell line:HuH-6	10633-108I3	13.08	1.19	3.57	2.38	0.00	0.00	0.00	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	100.88	9.17	6.41	4.09	0.88	0.88	0.00	0.11
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	102.32	10.68	5.95	7.04	0.85	1.09	0.00	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	99.84	9.80	6.87	3.94	1.52	0.71	0.00	0.00
hepatoma cell line:Li-7	10484-107A7	3.45	1.45	2.34	0.44	0.56	0.22	0.00	0.00
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	69.04	9.05	3.22	2.31	1.01	0.70	4.32	0.10
hippocampus - adult, donor10196	10169-103B7	19.87	1.89	31.23	12.30	4.73	2.84	0.00	0.00
hippocampus, adult, donor10252	10153-102I9	32.86	6.33	38.17	24.90	9.39	4.08	0.00	0.00
hippocampus, adult, donor10258	10374-105G5	30.37	3.98	20.91	7.97	2.49	1.00	0.00	0.50
hippocampus, newborn, donor10223	10363-105F3	10.22	2.11	6.70	3.52	1.06	1.41	0.35	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	58.59	27.47	4.27	6.71	0.61	0.61	0.00	0.61
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	48.50	17.08	3.73	3.34	0.98	0.39	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	58.14	18.79	4.06	2.79	0.76	1.02	0.00	0.25
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	23.68	7.89	11.84	1.69	1.69	1.69	0.00	0.56
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	21.17	8.26	7.23	4.91	2.58	0.77	0.00	1.03
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	25.05	13.67	6.07	2.66	1.52	0.76	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	13.14	7.01	7.88	2.92	4.09	2.34	0.00	0.29
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	18.74	6.03	12.71	4.31	6.03	2.80	0.00	0.65
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	20.02	6.67	12.10	2.50	1.67	2.92	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	25.10	13.26	16.10	2.84	1.18	3.08	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	19.77	6.91	15.11	4.34	3.05	3.54	0.00	0.48
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	36.36	10.77	8.75	1.35	2.69	2.69	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	41.47	10.48	3.29	3.76	1.41	0.31	0.00	0.47
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	36.36	10.81	2.95	2.95	0.49	0.00	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	56.73	18.33	7.85	6.11	0.87	0.00	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	30.93	11.65	4.39	3.44	1.53	0.38	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	30.53	12.21	5.67	3.05	1.74	0.44	0.00	0.44
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	31.48	10.00	7.00	2.00	1.00	0.00	0.00	0.50
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	16.96	8.67	9.04	4.33	1.88	0.57	0.00	0.19
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	13.64	6.37	12.28	4.09	3.64	0.00	0.00	1.82
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	17.54	5.95	6.58	4.07	1.88	0.31	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	21.56	6.86	6.04	3.10	1.14	0.65	0.00	0.49
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	23.52	6.68	4.94	4.64	1.45	0.29	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	11.96	8.07	6.58	3.89	1.20	0.60	0.00	0.60
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	48.96	16.63	5.17	2.59	1.85	0.55	0.00	0.18
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	51.64	19.11	6.56	5.14	1.71	0.29	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	61.66	27.77	4.08	4.90	2.04	1.63	0.00	0.41
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	37.67	13.38	9.15	4.58	2.46	0.70	0.00	1.06
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	41.81	16.15	5.07	4.12	1.90	0.63	0.00	0.95
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	40.25	15.13	9.99	4.84	1.51	1.21	0.00	0.30
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	24.30	7.76	13.45	3.62	4.14	0.52	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	29.22	11.29	17.93	3.98	1.33	1.33	0.00	0.66
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	15.65	4.36	6.67	2.82	0.77	0.77	0.00	0.26
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	26.59	12.53	11.50	5.37	1.79	1.53	0.00	0.26
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	19.69	6.06	12.87	3.03	1.51	0.76	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	32.26	10.75	9.07	4.03	1.68	1.34	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	67.62	19.32	7.97	1.93	0.48	0.72	0.00	0.24
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	64.17	29.41	4.01	6.24	1.78	0.45	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	46.83	28.29	3.41	1.95	0.98	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	31.78	10.39	11.61	3.67	2.44	0.31	0.00	0.31
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	16.27	42.29	6.51	6.51	3.25	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	45.34	21.84	8.60	4.63	2.98	1.99	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	30.65	9.85	11.49	4.93	3.28	1.64	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	28.59	7.96	13.03	5.43	5.79	1.45	0.00	0.36
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	29.54	7.12	14.59	4.98	3.91	1.42	0.00	0.36
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	13.13	2.39	16.71	7.16	2.39	1.19	0.00	1.19
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	32.64	10.29	18.69	4.60	2.98	3.93	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	12.93	5.39	10.51	2.96	1.08	0.54	0.00	0.00
immature langerhans cells, donor1	11904-125F5	58.12	12.59	11.38	5.09	1.45	1.70	1.70	0.24
immature langerhans cells, donor2	11905-125F6	23.76	6.34	6.34	0.79	0.00	0.00	0.79	0.00
insula, adult, pool1	10039-101F3	33.78	7.38	37.29	11.36	6.62	5.39	0.00	0.09
keratoacanthoma cell line:HKA-1	10791-110H8	216.87	25.04	14.63	13.98	2.28	1.30	0.00	0.33
kidney, adult, pool1	10017-101C8	35.55	7.91	8.61	5.21	1.00	0.60	0.10	0.00
kidney, fetal, pool1	10045-101F9	32.33	7.50	15.00	5.23	2.48	2.26	0.14	0.00
large cell lung carcinoma cell line:IA-LM	10509-107D5	16.62	5.96	4.69	3.27	0.71	0.28	0.28	0.00
large cell lung carcinoma cell line:NCI-H460	10839-111E2	42.16	4.01	12.72	8.29	1.80	1.24	0.00	0.28
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	33.21	6.24	1.83	2.75	0.73	0.00	0.00	0.00
left atrium, adult, donor1	10079-102A7	54.49	7.08	10.90	7.08	1.09	1.09	0.00	0.54
left ventricle, adult, donor1	10078-102A6	20.73	4.55	3.03	2.53	1.01	0.51	0.00	0.51
leiomyoblastoma cell line:G-402	10721-110A1	20.52	12.86	4.10	2.19	0.00	0.55	0.00	0.27
leiomyoma cell line:10964C	10569-108B2	57.48	10.42	16.53	10.78	1.08	4.67	0.00	0.00
leiomyoma cell line:15242A	10570-108B3	51.63	10.33	11.41	7.61	1.63	0.54	0.00	1.63
leiomyoma cell line:15425	10571-108B4	45.16	6.80	18.21	12.38	1.70	1.46	0.00	0.00
leiomyosarcoma cell line:Hs 5.T	10722-110A2	12.70	0.00	12.70	0.00	0.00	0.00	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	10.46	8.36	6.27	3.14	0.00	2.09	0.00	0.00
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	17.83	4.01	7.44	2.24	1.42	1.65	4.25	0.00
liposarcoma cell line:KMLS-1	10782-110G8	35.30	10.47	10.93	7.19	2.34	1.09	0.00	0.00
liposarcoma cell line:SW 872	10726-110A6	20.71	5.12	6.34	2.80	1.10	0.12	0.00	0.12
liver, adult, pool1	10018-101C9	29.82	10.86	5.19	2.59	0.32	0.65	0.00	0.00
liver, fetal, pool1	10086-102B5	13.17	2.82	4.70	3.76	0.00	0.94	0.00	0.00
locus coeruleus - adult, donor10196	10182-103D2	29.16	4.08	33.98	14.14	4.81	5.40	0.00	0.00
locus coeruleus, adult, donor10252	10165-103B3	39.68	4.06	29.16	19.19	6.27	2.77	0.00	0.18
locus coeruleus, adult, donor10258	10375-105G6	40.06	4.80	21.44	16.08	5.92	4.23	0.28	0.85
locus coeruleus, newborn, donor10223	10362-105F2	31.55	5.05	36.59	12.20	2.94	3.36	0.00	0.00
lung adenocarcinoma cell line:A549	10499-107C4	20.21	4.43	5.40	2.77	0.55	0.42	0.00	0.00
lung adenocarcinoma cell line:PC-14	10408-106B3	35.85	13.79	9.65	7.58	2.76	0.69	0.00	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	27.68	7.78	9.75	8.17	4.22	0.26	1.85	0.00
lung, adult, pool1	10019-101D1	127.58	13.23	14.06	7.09	2.13	1.18	0.24	0.59
lung, fetal, donor1	10068-101I5	49.66	12.56	28.54	12.56	4.28	3.71	0.86	0.00
lung, right lower lobe, adult, donor1	10075-102A3	175.50	11.00	12.37	12.37	2.29	1.37	0.46	1.37
lymph node, adult, donor1	10077-102A5	124.49	16.09	16.57	8.05	1.89	1.42	0.95	0.00
lymphangiectasia cell line:DS-1	10727-110A7	249.42	14.90	9.64	9.21	3.73	1.75	0.00	0.44
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	155.76	7.24	3.17	3.92	1.36	0.30	1.66	0.00
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	64.56	9.34	15.29	10.19	0.85	2.55	3.40	0.00
mature adipocyte, donor1	12231-129F8	39.96	12.88	24.42	10.66	1.78	4.88	0.00	0.00
mature adipocyte, donor2	12232-129F9	38.60	13.07	27.60	8.92	4.15	2.08	0.00	0.21
mature adipocyte, donor3	12233-129G1	53.81	19.20	23.94	13.99	4.27	1.90	0.00	0.00
mature adipocyte, donor4	12234-129G2	24.74	13.16	23.43	6.05	4.21	1.58	0.00	0.00
maxillary sinus tumor cell line:HSQ-89	10414-106B9	5.48	2.14	6.91	2.14	0.95	1.19	0.00	0.00
medial frontal gyrus - adult, donor10196	10170-103B8	16.92	2.26	20.30	4.51	3.38	2.26	0.00	0.00
medial frontal gyrus, adult, donor10252	10150-102I6	27.95	6.80	23.91	15.63	4.97	2.57	0.00	0.18
medial frontal gyrus, adult, donor10258	10368-105F8	20.97	2.86	13.03	7.31	3.18	0.95	0.00	0.00
medial frontal gyrus, newborn, donor10223	10352-105E1	15.78	5.12	8.96	5.12	0.00	1.28	0.00	0.00
medial temporal gyrus - adult, donor10196	10183-103D3	17.21	2.36	25.14	15.53	3.38	2.36	0.00	0.84
medial temporal gyrus, adult, donor10252	10156-103A3	32.05	5.52	31.62	19.52	5.31	3.18	0.00	0.21
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	15.41	7.71	9.63	1.93	1.93	3.85	0.00	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	14.35	0.00	43.06	14.35	0.00	0.00	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	16.15	2.87	3.95	0.72	0.72	0.36	0.00	0.00
medulla oblongata - adult, donor10196	10174-103C3	25.96	5.19	35.69	12.33	8.44	5.19	0.00	0.00
medulla oblongata, adult, donor10252	10155-103A2	50.78	6.97	33.59	20.28	5.57	2.63	0.00	0.00
medulla oblongata, adult, pool1	10038-101F2	75.91	10.29	70.12	20.08	10.94	8.57	0.00	0.08
medulla oblongata, newborn, donor10223	10361-105F1	27.08	4.86	32.29	11.11	5.21	4.51	0.00	0.35
medulloblastoma cell line:D283 Med	10838-111E1	8.86	11.07	5.98	2.88	1.55	0.22	0.00	0.22
medulloblastoma cell line:ONS-76	10759-110E3	68.11	11.37	12.23	6.97	1.35	1.47	0.00	0.00
melanoma cell line:COLO 679	10514-107E1	61.09	16.10	11.21	5.61	3.31	1.29	0.00	0.14
melanoma cell line:G-361	10465-106H6	55.65	17.37	12.76	7.33	2.71	1.90	0.00	0.00
meningioma cell line:HKBMM	10691-109F7	10.85	3.08	1.81	2.17	1.09	0.36	0.36	0.00
merkel cell carcinoma cell line:MKL-1	10843-111E6	1.76	3.52	6.17	0.88	0.00	0.00	0.00	0.00
merkel cell carcinoma cell line:MS-1	10844-111E7	1.81	1.30	0.00	0.26	0.00	0.00	0.00	0.00
mesenchymal precursor cell - adipose, donor1	11747-123G1	29.31	13.66	7.83	3.99	0.77	1.38	0.00	0.15
mesenchymal precursor cell - adipose, donor2	11748-123G2	17.45	7.82	6.73	2.18	1.45	0.73	0.00	0.00
mesenchymal precursor cell - adipose, donor3	11749-123G3	31.89	19.05	10.77	4.14	0.83	2.07	0.00	0.00
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	38.91	10.25	9.41	5.48	1.40	0.84	0.00	0.14
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	45.45	12.32	13.09	5.78	1.54	1.54	0.00	0.19
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	38.17	12.49	17.35	7.63	2.08	1.39	0.00	0.00
mesenchymal precursor cell - cardiac, donor1	11752-123G6	42.74	11.50	10.47	5.32	0.17	1.72	0.00	0.17
mesenchymal precursor cell - cardiac, donor2	11753-123G7	33.01	11.85	7.25	6.33	1.38	0.58	0.00	0.12
mesenchymal precursor cell - cardiac, donor3	11754-123G8	31.43	15.52	6.50	2.52	0.80	0.66	0.00	0.13
mesenchymal precursor cell - cardiac, donor4	11755-123G9	35.52	12.42	8.51	3.38	1.89	1.22	0.00	0.14
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	33.29	8.39	4.55	3.13	1.56	0.28	0.00	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	40.51	20.75	14.82	3.29	1.32	1.65	0.00	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	28.23	10.38	5.53	2.35	0.69	0.55	0.00	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	56.20	19.20	15.01	10.47	1.05	1.40	0.00	0.35
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	33.07	8.57	5.10	3.47	2.65	0.41	0.00	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	38.10	10.06	8.99	5.75	1.08	1.08	0.00	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	43.66	11.59	12.21	5.79	2.07	1.34	0.00	0.31
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	75.01	13.00	9.12	4.33	0.68	0.91	0.00	0.23
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	48.67	10.49	11.75	3.36	1.68	0.42	0.00	0.42
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	27.94	7.47	7.32	2.84	0.90	1.05	0.00	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	34.92	10.24	5.16	3.50	0.61	0.35	0.00	0.18
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	53.01	12.15	12.89	9.57	2.95	2.21	0.00	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	35.20	8.58	13.74	4.29	0.86	0.29	0.00	0.29
mesenchymal stem cell line:Hu5/E18	10568-108B1	19.79	8.84	7.16	5.05	0.42	0.42	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	17.35	14.61	11.42	2.28	1.37	2.74	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	22.25	13.30	13.81	3.07	1.28	2.56	0.00	0.26
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	21.73	15.71	13.09	2.36	1.83	1.57	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	23.41	16.33	10.78	4.31	0.92	1.85	0.00	0.31
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	20.24	13.18	11.30	4.47	0.94	1.65	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	25.72	15.57	15.91	5.08	0.34	1.02	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	26.33	12.18	14.54	1.57	0.79	1.96	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	19.46	13.90	11.58	1.85	1.85	0.46	0.00	0.46
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	31.73	15.86	14.13	4.61	0.58	1.73	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	28.11	13.83	14.72	6.02	0.67	1.12	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	22.59	12.98	13.94	4.57	1.20	1.92	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	29.33	19.07	17.60	9.53	0.73	3.67	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	22.15	10.07	14.10	4.03	1.34	0.67	0.00	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	24.97	12.69	14.74	2.05	0.82	0.82	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	20.62	11.17	10.31	3.01	1.29	0.86	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	19.14	5.47	10.94	2.73	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	5.16	30.99	10.33	10.33	5.16	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	20.46	15.26	8.44	4.55	0.32	1.95	0.00	0.32
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	24.73	10.18	5.82	8.73	1.45	1.45	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	21.32	11.73	11.19	6.40	0.53	1.07	0.00	0.53
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	19.63	15.54	7.36	3.27	0.82	0.82	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	17.10	13.61	10.50	3.89	0.78	0.78	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	12.59	23.09	8.39	6.30	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	17.88	11.92	16.89	4.97	0.99	1.99	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	38.14	4.77	4.77	0.00	4.77	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	18.97	10.08	7.12	4.15	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	28.02	19.50	7.31	8.53	0.00	1.22	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	0.00	54.10	27.05	0.00	0.00	27.05	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	20.27	17.73	8.23	4.43	1.27	0.63	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	21.38	16.90	7.93	3.79	0.69	1.38	0.00	0.69
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	17.19	15.04	10.75	4.30	4.30	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	23.95	19.96	15.97	3.99	3.99	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	44.77	20.66	24.11	10.33	0.00	0.00	0.00	3.44
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	26.89	15.48	9.78	4.89	1.63	0.81	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	28.60	15.89	9.53	7.15	3.18	1.59	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	15.33	12.38	19.45	8.84	0.59	2.36	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	22.44	8.42	12.16	6.23	1.56	2.81	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	33.42	6.68	16.04	12.03	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	17.74	3.55	16.56	0.00	0.00	2.37	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	17.98	7.70	17.98	5.14	0.00	2.57	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	15.14	11.01	16.52	4.82	1.38	1.38	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	25.73	6.93	17.32	4.45	0.99	2.97	0.00	0.49
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	20.19	5.61	22.43	7.85	0.00	1.12	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	24.17	4.45	15.90	4.45	1.91	1.91	0.00	0.64
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	48.36	8.46	16.52	6.85	1.21	1.21	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	45.79	8.72	15.26	10.90	2.18	2.18	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	46.88	11.40	13.94	2.53	1.27	3.80	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	37.02	7.28	11.53	3.64	0.61	0.61	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	49.71	13.56	18.08	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	41.18	5.77	8.24	1.65	0.82	0.82	0.00	0.82
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	16.47	8.93	13.10	5.16	2.58	2.18	0.00	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	19.79	5.19	12.33	4.54	0.97	2.60	0.00	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	24.45	7.13	17.32	6.11	2.04	4.07	0.00	0.00
mesodermal tumor cell line:HIRS-BM	10696-109G3	3.09	0.77	3.87	2.32	2.32	0.77	0.00	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	42.05	7.80	19.61	5.43	4.96	2.36	0.00	0.24
mesothelioma cell line:ACC-MESO-4	10494-107B8	9.50	1.16	2.09	0.93	0.70	0.23	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	12.82	0.00	4.27	0.00	0.00	0.00	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	8.32	4.42	2.16	1.44	0.21	0.41	0.00	0.00
mesothelioma cell line:Mero-25	10850-111F4	0.91	0.45	0.68	0.23	0.00	0.00	0.00	0.00
mesothelioma cell line:Mero-41	10851-111F5	15.89	8.56	8.56	3.91	0.73	0.98	0.00	0.00
mesothelioma cell line:Mero-48a	10852-111F6	29.23	9.96	11.29	5.31	0.22	0.44	0.00	0.00
mesothelioma cell line:Mero-82	10853-111F7	9.20	2.63	4.99	0.53	1.31	0.26	0.00	0.00
mesothelioma cell line:Mero-83	10854-111F8	3.92	1.70	0.51	0.51	0.00	0.17	0.00	0.00
mesothelioma cell line:Mero-84	10855-111F9	22.50	5.56	3.79	2.53	1.26	0.76	0.00	0.25
mesothelioma cell line:Mero-95	10856-111G1	20.70	11.39	5.38	3.93	1.04	0.00	0.00	0.21
mesothelioma cell line:NCI-H2052	10847-111F1	51.68	16.56	9.61	4.64	1.49	1.16	0.17	0.66
mesothelioma cell line:NCI-H226	10846-111E9	5.25	1.09	0.72	0.72	0.36	0.00	0.00	0.00
mesothelioma cell line:NCI-H2452	10848-111F2	4.27	2.90	3.07	0.85	0.17	0.34	0.00	0.00
mesothelioma cell line:NCI-H28	10845-111E8	8.14	5.09	2.80	0.51	0.76	1.02	0.00	0.00
mesothelioma cell line:No36	10857-111G2	0.98	0.33	0.98	0.33	0.00	0.00	0.00	0.00
mesothelioma cell line:ONE58	10858-111G3	22.49	6.50	4.34	2.98	0.00	0.27	0.00	0.27
migratory langerhans cells, donor1	11901-125F2	103.25	37.81	14.97	9.21	2.88	1.54	0.38	0.00
migratory langerhans cells, donor2	11902-125F3	80.23	24.30	16.24	9.77	3.54	1.47	0.37	0.12
migratory langerhans cells, donor3	11903-125F4	150.05	37.69	12.56	9.69	3.59	2.33	0.36	0.00
mixed mullerian tumor cell line:HTMMT	10689-109F5	15.67	4.24	5.22	4.57	2.29	0.33	0.00	0.00
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	19.29	3.18	1.06	1.48	1.06	0.21	0.00	0.21
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	18.66	3.92	6.45	3.69	0.23	0.92	0.00	0.00
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	77.64	12.75	13.32	5.71	2.47	1.52	8.75	0.00
myelodysplastic syndrome cell line:SKM-1	10772-110F7	55.25	9.79	14.41	4.07	1.48	0.74	0.00	0.00
myeloma cell line:PCM6	10474-106I6	111.29	28.07	11.07	8.10	1.19	0.20	0.00	0.20
myxofibrosarcoma cell line:MFH-ino	10600-108E6	10.65	4.06	1.52	2.54	0.00	0.00	0.00	0.00
myxofibrosarcoma cell line:NMFH-1	10684-109E9	29.03	14.51	15.50	5.49	0.98	0.59	0.00	0.20
nasal epithelial cells, donor1, tech_rep1	12226-129F3	213.94	20.61	18.94	12.15	7.58	2.79	0.00	0.11
nasal epithelial cells, donor1, tech_rep2	12226-129F3	212.16	21.33	24.71	17.13	8.68	3.68	0.00	0.29
nasal epithelial cells, donor2	12227-129F4	206.44	38.09	17.11	12.14	7.18	1.66	0.00	1.10
neuroblastoma cell line:CHP-134	10508-107D4	4.14	2.30	2.30	0.46	0.23	0.00	0.00	0.00
neuroblastoma cell line:NB-1	10539-107G8	9.92	5.61	6.17	0.37	0.94	0.75	0.00	0.00
neuroblastoma cell line:NBsusSR	10607-108F4	2.95	0.84	3.80	1.27	2.11	0.84	0.00	0.00
neuroblastoma cell line:NH-12	10555-107I6	6.15	3.54	8.57	1.12	2.05	1.30	0.00	0.00
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	0.47	0.47	0.47	0.00	0.24	0.00	0.00	0.00
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	7.76	1.27	4.59	4.59	2.53	0.00	0.00	0.00
neuroectodermal tumor cell line:TASK1	10774-110F9	8.45	3.82	4.83	1.81	2.21	0.60	0.00	0.40
neuroepithelioma cell line:SK-N-MC	10728-110A8	4.45	1.91	0.64	0.64	0.64	0.00	0.00	0.00
neurofibroma cell line:Hs 53.T	10729-110A9	11.98	4.79	5.32	1.60	0.53	0.53	0.00	0.00
neutrophil PMN, donor1	12133-128D9	14.87	0.00	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	13.28	0.00	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	9.47	0.00	0.00	0.00	0.00	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	17.25	5.24	5.24	1.69	3.89	0.68	0.17	0.00
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	4.00	0.00	2.40	0.80	0.80	0.80	0.00	0.00
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	10.26	6.09	8.98	2.56	2.56	1.60	0.00	0.00
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	20.76	6.04	8.15	5.52	1.31	0.53	0.00	0.26
nucleus accumbens, adult, pool1	10037-101F1	37.78	7.22	48.84	11.81	9.28	7.59	0.00	0.09
occipital cortex - adult, donor10196	10172-103C1	6.18	2.06	35.03	8.24	4.12	10.30	0.00	0.00
occipital cortex, adult, donor10252	10163-103B1	37.57	4.56	31.94	23.88	6.98	2.68	0.00	0.54
occipital cortex, newborn, donor10223	10355-105E4	23.66	2.18	8.01	4.00	0.73	0.73	0.00	0.00
occipital lobe, adult, donor1	10076-102A4	26.24	3.67	32.01	17.58	5.77	1.31	0.00	0.26
occipital lobe, fetal, donor1	10073-102A1	4.29	0.43	3.00	2.57	0.86	2.57	0.00	0.00
occipital pole, adult, pool1	10036-101E9	33.43	5.83	33.67	7.96	6.94	5.52	0.00	0.08
olfactory region, adult	10195-103E6	21.97	5.16	43.75	13.95	8.22	6.30	0.00	0.00
optic nerve, donor1	10277-104E7	32.02	0.00	92.05	16.01	8.00	14.01	0.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	80.42	11.39	7.86	2.62	0.80	1.37	0.00	0.00
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	90.81	17.59	1.92	2.47	1.10	0.27	0.14	0.00
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	214.53	20.66	10.33	17.95	1.52	1.35	0.00	1.02
oral squamous cell carcinoma cell line:SAS	10544-107H4	7.97	6.82	1.96	1.73	0.35	0.12	0.00	0.00
osteoclastoma cell line:Hs 706.T	10704-109H2	12.64	8.82	8.23	2.94	1.18	0.00	0.00	0.00
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	11.21	3.74	4.67	1.87	0.00	0.00	0.00	0.00
osteosarcoma cell line:HS-Os-1	10558-107I9	43.47	14.84	16.54	4.88	2.76	3.82	0.00	0.00
ovary, adult, pool1	10020-101D2	35.29	7.69	20.61	7.69	3.41	2.36	0.00	0.09
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	19.98	4.40	3.12	1.47	0.73	0.18	0.00	0.37
pancreas, adult, donor1	10049-101G4	16.93	15.05	15.99	6.58	5.64	3.76	0.00	0.00
pancreatic carcinoma cell line:NOR-P1	10698-109G5	676.48	16.21	2.80	13.70	1.12	0.28	0.00	0.28
papillary adenocarcinoma cell line:8505C	10437-106E5	19.93	7.33	4.60	4.60	0.17	0.68	0.17	0.34
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	25.00	5.13	3.64	1.99	0.83	0.66	0.00	0.00
paracentral gyrus, adult, pool1	10035-101E8	41.37	8.51	40.82	12.17	7.23	5.77	0.00	0.27
parietal cortex, adult, donor10258	10373-105G4	23.49	5.14	22.75	11.01	4.40	1.47	0.73	0.00
parietal lobe - adult, donor10196	10171-103B9	24.45	4.70	16.93	6.58	1.88	2.82	0.00	0.00
parietal lobe, adult, donor10252	10157-103A4	21.95	3.99	28.22	12.83	4.85	3.42	0.00	0.00
parietal lobe, adult, pool1	10034-101E7	38.07	5.46	48.29	11.10	9.08	5.82	0.00	0.00
parietal lobe, fetal, donor1	10072-101I9	4.85	1.94	8.73	2.91	2.91	0.97	0.00	0.00
parietal lobe, newborn, donor10223	10356-105E5	19.44	1.50	11.22	3.74	1.50	1.50	0.00	0.00
parotid gland, adult	10199-103F1	40.08	8.02	8.63	2.47	4.32	1.23	0.00	0.00
penis, adult	10200-103F2	43.51	8.06	19.34	9.67	0.54	2.69	0.00	0.54
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	0.19	0.00	0.93	0.00	0.93	0.19	0.00	0.00
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	80.71	15.74	8.89	4.52	1.89	0.58	0.00	0.15
pineal gland - adult, donor10196	10179-103C8	13.55	0.65	13.55	7.10	0.65	4.52	0.00	0.00
pineal gland, adult, donor10252	10160-103A7	14.81	4.15	15.40	7.11	7.11	1.78	0.00	0.00
pineal gland, adult, donor10258	10377-105G8	13.17	4.39	15.05	5.02	2.51	0.63	0.00	0.00
pituitary gland - adult, donor10196	10180-103C9	21.25	3.04	17.20	7.08	3.04	2.02	1.01	0.00
pituitary gland, adult, donor10252	10162-103A9	31.27	1.04	15.64	7.82	1.56	1.56	0.00	0.00
pituitary gland, adult, donor10258	10378-105G9	23.83	6.81	8.51	2.55	0.85	1.70	0.00	0.00
placenta, adult, pool1	10021-101D3	601.91	13.55	46.66	34.62	7.74	6.56	0.00	0.54
plasma cell leukemia cell line:ARH-77	10840-111E3	147.92	10.06	4.24	7.55	2.78	0.93	4.50	0.26
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	19.14	7.00	18.52	7.16	3.27	2.49	0.00	0.16
pons, adult, pool1	10033-101E6	65.07	9.98	51.21	12.57	6.46	5.77	0.00	0.00
postcentral gyrus, adult, pool1	10032-101E5	29.73	6.54	37.49	11.16	7.50	5.49	0.09	0.00
promyelocytes/myelocytes PMC, donor1	12132-128D8	100.39	23.01	4.18	0.00	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	60.59	5.51	16.52	5.51	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	105.62	35.21	35.21	11.74	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	45.88	13.55	4.22	3.35	0.87	0.44	0.00	0.29
prostate cancer cell line:PC-3	10439-106E7	141.75	44.83	8.89	4.90	0.91	1.45	0.18	0.18
prostate, adult, pool1	10022-101D4	41.99	11.79	22.58	8.43	3.45	3.08	0.00	0.00
putamen, adult, donor10196	10176-103C5	21.01	2.83	30.45	11.80	7.55	4.96	0.00	0.24
putamen, adult, donor10252	10152-102I8	15.69	11.76	25.49	17.65	3.92	0.00	0.00	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	44.81	8.74	19.67	4.37	1.09	1.09	0.00	0.00
putamen, adult, donor10258, tech_rep2	10372-105G3	28.99	4.83	24.64	8.46	6.28	3.38	0.00	0.48
putamen, newborn, donor10223	10365-105F5	27.74	9.00	31.49	14.99	3.75	4.50	0.00	0.00
rectal cancer cell line:TT1TKB	10469-106I1	90.77	5.53	8.73	2.33	0.87	0.87	0.00	0.00
rectum, fetal, donor1	10067-101I4	16.69	11.13	12.52	0.00	1.39	1.39	0.00	0.00
renal cell carcinoma cell line:OS-RC-2	10411-106B6	21.41	3.82	9.75	4.88	4.03	1.48	0.00	0.00
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	16.15	12.84	9.11	4.14	2.07	0.00	0.00	0.00
retina, adult, pool1	10030-101E3	53.08	12.62	44.23	12.82	6.16	4.17	0.10	0.10
retinoblastoma cell line:Y79	10475-106I7	8.05	8.31	3.64	0.78	0.52	1.04	0.00	0.00
rhabdomyosarcoma cell line:KYM-1	10787-110H4	13.77	4.43	2.83	0.98	0.61	0.49	0.00	0.00
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	7.59	3.09	1.97	0.56	1.41	0.00	0.00	0.00
sacrococcigeal teratoma cell line:HTST	10695-109G2	18.19	3.79	4.55	3.03	1.52	0.00	0.00	0.00
salivary acinar cells, donor1	11771-123I7	269.81	51.96	13.92	16.83	1.78	1.46	0.00	0.49
salivary acinar cells, donor2	11772-123I8	378.23	49.02	26.85	32.91	3.03	3.03	0.00	1.38
salivary acinar cells, donor3	11773-123I9	184.71	17.21	7.28	9.93	1.32	0.66	0.00	0.00
salivary gland, adult, pool1	10093-102C3	43.47	13.73	13.73	9.15	7.44	5.72	0.00	0.00
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	81.19	20.66	15.01	8.35	1.18	0.76	0.67	0.08
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	66.42	19.87	12.11	7.76	1.53	0.82	0.35	0.00
seminal vesicle, adult	10201-103F3	31.74	12.70	15.87	6.88	4.76	1.06	0.00	1.06
serous adenocarcinoma cell line:JHOS-2	10639-108I9	40.33	6.07	14.33	11.17	3.16	0.73	0.00	0.00
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	31.20	5.79	5.03	4.78	1.51	0.50	1.26	0.25
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	38.13	14.05	12.04	6.02	0.00	0.00	3.01	0.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	27.27	1.61	3.36	2.28	0.54	0.54	0.00	0.00
signet ring carcinoma cell line:Kato III	10436-106E4	10.94	3.76	1.33	1.99	0.55	0.11	0.00	0.00
signet ring carcinoma cell line:NUGC-4	10483-107A6	22.19	15.87	3.61	1.81	0.52	0.65	0.00	0.00
skeletal muscle - soleus muscle, donor1	10282-104F3	2.84	0.71	0.71	0.00	0.00	0.00	0.00	0.00
skeletal muscle, adult, pool1	10023-101D5	14.87	3.48	5.40	1.56	0.72	0.72	0.00	0.00
skeletal muscle, fetal, donor1	10066-101I3	18.09	4.02	7.04	2.01	1.01	2.01	0.00	0.00
skin, adult, donor1	10074-102A2	203.56	13.57	20.36	6.79	6.79	0.00	0.00	0.00
skin, fetal, donor1	10065-101I2	32.82	13.26	16.41	3.16	3.79	1.26	0.63	0.00
small cell cervical cancer cell line:HCSC-1	10800-110I8	10.34	3.00	1.67	0.00	0.67	0.00	0.00	0.00
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	9.77	2.84	5.99	2.21	2.52	0.32	0.00	0.00
small cell lung carcinoma cell line:DMS 144	10841-111E4	37.39	1.73	24.29	9.83	4.63	3.47	0.00	0.19
small cell lung carcinoma cell line:LK-2	10541-107H1	18.13	7.75	6.43	0.66	0.82	0.49	0.00	0.00
small cell lung carcinoma cell line:NCI-H82	10842-111E5	7.24	3.70	2.41	0.64	2.09	0.64	0.00	0.00
small cell lung carcinoma cell line:WA-hT	10562-108A4	18.09	3.27	4.58	1.31	0.44	0.44	0.00	0.22
small intestine, adult, pool1	10024-101D6	51.96	11.23	13.62	4.66	1.55	1.79	0.24	0.12
small intestine, fetal, donor1	10064-101I1	24.82	8.60	7.13	7.37	0.49	0.00	0.74	0.00
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	0.51	0.00	1.03	0.51	0.00	0.00	0.00	0.00
smooth muscle, adult, pool1	10048-101G3	20.68	11.37	19.13	8.01	2.33	1.55	0.00	0.00
somatostatinoma cell line:QGP-1	10781-110G7	3.48	2.68	3.48	1.34	0.80	0.54	0.00	0.00
spinal cord - adult, donor10196	10181-103D1	36.70	6.19	50.70	28.45	7.57	5.28	0.00	0.46
spinal cord, adult, donor10252	10159-103A6	120.65	12.22	50.86	32.33	13.01	5.13	0.00	0.00
spinal cord, adult, donor10258	10369-105F9	92.70	15.91	66.41	29.06	8.30	8.30	0.00	0.00
spinal cord, fetal, donor1	10056-101H2	40.25	6.71	36.59	12.81	12.81	5.49	0.00	0.61
spinal cord, newborn, donor10223	10359-105E8	28.93	5.51	47.76	22.50	3.67	3.21	0.00	0.00
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	6.42	4.03	6.87	1.79	0.75	0.75	0.00	0.00
spleen, adult, pool1	10025-101D7	150.33	19.27	14.76	7.27	1.98	1.54	1.54	0.22
spleen, fetal, pool1	10044-101F8	110.52	12.71	13.98	5.72	2.78	1.59	7.63	0.00
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	247.39	16.56	5.59	8.28	1.04	0.52	0.72	0.10
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	168.99	10.44	11.39	9.87	2.28	1.71	0.00	0.19
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	80.02	6.29	26.56	14.33	2.10	6.64	0.00	0.00
squamous cell carcinoma cell line:T3M-5	10616-108G4	25.02	3.91	3.91	4.69	0.78	0.78	0.00	0.39
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	5.63	1.80	8.44	3.04	0.68	0.68	0.00	0.00
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	20.33	4.24	5.93	2.97	0.85	0.85	0.00	0.00
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	27.92	7.62	2.54	4.65	0.42	0.00	0.00	0.00
stomach, fetal, donor1	10062-101H8	18.16	6.41	6.41	5.34	1.07	0.00	0.00	1.07
submaxillary gland, adult	10202-103F4	35.32	9.68	10.82	5.13	1.14	1.71	0.00	0.00
substantia nigra - adult, donor10196	10178-103C7	0.00	0.00	54.27	54.27	0.00	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	66.26	6.44	50.06	30.12	9.35	2.70	0.00	0.42
substantia nigra, adult, donor10258	10371-105G2	48.10	4.66	33.10	16.03	4.14	2.07	0.00	0.00
substantia nigra, newborn, donor10223	10358-105E7	24.73	3.53	31.80	13.42	2.12	5.65	0.00	0.00
synovial sarcoma cell line:HS-SY-II	10441-106E9	16.05	2.29	4.59	1.83	0.69	1.60	0.00	0.00
temporal lobe, adult, pool1	10031-101E4	33.40	5.51	40.69	11.70	5.93	6.44	0.00	0.17
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	7.83	1.42	4.99	1.42	3.56	0.00	0.00	0.00
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	7.03	1.76	4.83	1.32	0.00	0.88	0.00	0.00
tenocyte, donor1	11763-123H8	35.26	10.47	12.92	6.98	1.40	1.05	0.00	0.00
tenocyte, donor2	11765-123I1	20.98	8.39	18.69	9.92	2.29	1.91	0.00	0.00
tenocyte, donor3	11768-123I4	22.98	14.46	8.90	2.97	0.74	0.74	0.00	0.00
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	76.31	18.53	4.93	5.61	2.04	0.34	0.00	0.00
teratocarcinoma cell line:NCR-G1	10798-110I6	20.35	8.32	5.40	4.01	0.92	0.62	0.00	0.31
teratocarcinoma cell line:PA-1	10807-111A6	35.33	16.27	3.56	3.25	0.77	1.24	0.00	0.31
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	22.22	8.89	1.65	1.14	0.13	0.00	0.00	0.13
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	27.61	17.77	4.54	1.51	0.76	1.13	0.00	0.00
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	53.88	23.01	1.85	3.49	0.44	0.11	0.00	0.11
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	52.44	26.06	1.63	2.28	0.98	0.00	0.00	0.33
testis, adult, pool1	10026-101D8	66.36	11.27	19.33	7.52	2.79	2.68	0.21	0.64
testis, adult, pool2	10096-102C6	62.25	8.12	13.98	7.67	3.16	2.71	0.00	0.00
thalamus - adult, donor10196	10168-103B6	29.81	1.10	59.62	24.29	8.83	3.31	0.00	0.00
thalamus, adult, donor10252	10154-103A1	48.14	6.10	49.85	29.38	9.85	6.10	0.31	0.00
thalamus, adult, donor10258, tech_rep1	10370-105G1	52.35	0.00	35.41	15.40	7.70	1.54	0.00	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	27.50	7.41	20.75	12.19	5.76	3.13	0.00	0.16
thalamus, newborn, donor10223	10366-105F6	45.45	10.93	17.83	6.90	1.73	1.15	0.00	0.00
throat, adult	10209-103G2	51.93	10.74	8.24	6.24	1.75	1.75	0.00	0.25
throat, fetal, donor1	10061-101H7	20.11	5.79	11.88	3.35	2.13	0.91	2.74	0.30
thymic carcinoma cell line:Ty-82	10803-111A2	24.84	10.14	11.13	3.97	3.18	1.59	0.00	0.00
thymus, adult, pool1	10027-101D9	51.00	6.86	9.15	2.98	1.89	0.80	78.04	0.10
thymus, fetal, pool1	10043-101F7	72.63	8.83	8.62	4.47	4.16	1.25	94.66	0.10
thyroid carcinoma cell line:KHM-5M	10776-110G2	24.60	11.43	5.85	3.19	0.27	0.93	0.00	0.00
thyroid carcinoma cell line:TCO-1	10783-110G9	12.57	6.29	2.93	3.07	0.56	0.14	0.14	0.14
thyroid, adult, pool1	10028-101E1	22.40	7.28	10.17	4.67	2.05	1.31	0.00	0.09
thyroid, fetal, donor1	10060-101H6	21.09	5.01	16.87	5.54	3.43	2.11	0.00	0.00
tongue epidermis (fungiform papillae), donor1	10288-104F9	21.56	15.40	3.08	3.08	3.08	0.00	0.00	0.00
tongue, adult	10203-103F5	120.48	15.58	12.56	9.54	3.26	1.86	0.23	0.70
tongue, fetal, donor1	10059-101H5	46.90	9.06	13.01	9.46	2.76	1.97	0.00	0.00
tonsil, adult, pool1	10047-101G2	209.27	28.15	18.43	9.32	4.01	3.21	3.81	0.10
trachea, adult, pool1	10029-101E2	79.34	14.72	13.01	7.85	2.37	1.47	0.41	0.00
trachea, fetal, donor1	10058-101H4	30.39	4.62	11.93	7.31	2.31	2.31	0.00	0.00
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	15.23	10.27	8.15	2.83	0.71	0.00	0.00	0.00
transitional-cell carcinoma cell line:5637	10418-106C4	35.36	8.92	4.36	2.43	0.51	0.81	0.10	0.00
transitional-cell carcinoma cell line:JMSU1	10492-107B6	13.79	6.89	5.48	2.35	0.31	0.31	0.00	0.00
tridermal teratoma cell line:HGRT	10694-109G1	9.51	9.51	0.00	0.00	0.00	1.90	0.00	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	8.04	7.87	1.78	1.19	0.68	0.42	0.00	0.00
umbilical cord, fetal, donor1	10057-101H3	18.78	4.17	6.26	12.52	0.00	0.00	0.00	0.00
uterus, adult, pool1	10100-102D1	38.90	13.31	22.69	7.00	4.95	3.75	0.00	0.17
uterus, fetal, donor1	10055-101H1	41.47	4.10	10.24	8.19	3.58	0.00	0.00	0.00
vagina, adult	10204-103F6	30.37	2.58	9.05	4.52	0.00	0.00	0.00	0.00
vein, adult	10191-103E2	136.78	8.55	17.32	9.64	3.95	3.95	9.86	0.66
xeroderma pigentosum b cell line:XPL 17	10563-108A5	129.25	8.81	6.14	6.41	2.14	1.07	2.67	0.53